BE846194Q - DOSAGE BY ENZYMATIC AMPLIFICATION - Google Patents

DOSAGE BY ENZYMATIC AMPLIFICATION

Info

Publication number
BE846194Q
BE846194Q BE170633A BE170633A BE846194Q BE 846194 Q BE846194 Q BE 846194Q BE 170633 A BE170633 A BE 170633A BE 170633 A BE170633 A BE 170633A BE 846194 Q BE846194 Q BE 846194Q
Authority
BE
Belgium
Prior art keywords
dosage
enzymatic amplification
enzymatic
amplification
Prior art date
Application number
BE170633A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of BE846194Q publication Critical patent/BE846194Q/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BE170633A 1971-05-14 1976-09-14 DOSAGE BY ENZYMATIC AMPLIFICATION BE846194Q (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14360971A 1971-05-14 1971-05-14
US00304156A US3817837A (en) 1971-05-14 1972-11-06 Enzyme amplification assay

Publications (1)

Publication Number Publication Date
BE846194Q true BE846194Q (en) 1976-12-31

Family

ID=26841233

Family Applications (1)

Application Number Title Priority Date Filing Date
BE170633A BE846194Q (en) 1971-05-14 1976-09-14 DOSAGE BY ENZYMATIC AMPLIFICATION

Country Status (2)

Country Link
US (1) US3817837A (en)
BE (1) BE846194Q (en)

Families Citing this family (912)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630328B2 (en) 1909-07-15 2003-10-07 Genencor International, Inc. Increasing production of proteins in gram-positive microorganisms
US5677132A (en) * 1971-05-20 1997-10-14 Strahilevitz; Meir Immunological assay reagent package
US4375414A (en) * 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
DE2128670B2 (en) * 1971-06-09 1977-06-30 Merck Patent Gmbh, 6100 Darmstadt IMMUNOLOGICAL ISOENZYME DETERMINATION METHOD
NL171930C (en) * 1972-05-11 1983-06-01 Akzo Nv METHOD FOR DETERMINING AND DETERMINING BITES AND TEST PACKAGING.
US3878187A (en) * 1972-09-11 1975-04-15 Syva Co Polypeptide derivatives of amphetamine and analogs for immunoassays
DE2258822A1 (en) * 1972-12-01 1974-06-06 Merck Patent Gmbh METHODS AND MEANS OF ANALYSIS OF ISOENZYME PATTERNS
US3959078A (en) * 1973-05-18 1976-05-25 Midwest Research Institute Enzyme immobilization with a thermochemical-photochemical bifunctional agent
US4255329A (en) * 1973-10-02 1981-03-10 Syva Company Double receptor fluorescent immunoassay
GB1511571A (en) * 1974-06-28 1978-05-24 Syva Co Lactam compounds and conjugates
CA1028643A (en) * 1975-02-20 1978-03-28 Judith I. Blakemore Polylodothyronine immunoassay
US4043872A (en) * 1975-02-20 1977-08-23 Syva Company Polyiodothyronine immunoassay
US4171244A (en) * 1975-02-20 1979-10-16 Syva Company Enzyme-bound-polyidothyronine
US4025501A (en) * 1975-03-20 1977-05-24 Syva Company Polypeptide propoxyphene derivatives for immunoassay reagents
IN142734B (en) * 1975-04-28 1977-08-20 Miles Lab
US4629688A (en) * 1975-04-28 1986-12-16 Miles Laboratories, Inc. Homogeneous specific binding assay method
US4230797A (en) * 1975-04-28 1980-10-28 Miles Laboratories, Inc. Heterogenous specific binding assay employing a coenzyme as label
USRE32696E (en) * 1975-09-04 1988-06-14 Akzona Incorporated Enzymatic immunological method for determination of antigens and antibodies
US4642285A (en) * 1975-09-29 1987-02-10 Diamedix Corporation Sandwich EIA for antigen
US4474878A (en) * 1975-09-29 1984-10-02 Cordis Laboratories, Inc. Sandwich EIA for antigen associated with hepatitis
US4134792A (en) * 1976-12-06 1979-01-16 Miles Laboratories, Inc. Specific binding assay with an enzyme modulator as a labeling substance
US4069105A (en) * 1977-03-03 1978-01-17 Syva Company Lidocaine antigens and antibodies
IT1153999B (en) * 1977-03-15 1987-01-21 Snam Progetti COMPOSITION SUITABLE FOR DETERMINING TRIIODOTHYRONIN AND DIAGNOSTIC METHOD USING THE SAME
US4156081A (en) * 1977-04-15 1979-05-22 Syva Company Theophylline antigens and antibodies
US4233401A (en) * 1977-07-14 1980-11-11 Syva Company Antienzyme homogeneous competitive binding assay
IT1105734B (en) * 1977-07-14 1985-11-04 Syva Co TEST OF COMPETITION LINK OF HOMOGENEOUS ANTI-ENZYME
US4168207A (en) * 1977-08-03 1979-09-18 Syva Company TBG assay
US4239852A (en) * 1978-06-12 1980-12-16 Penicillin Assays, Inc. Antibiotic detection method
AU531777B2 (en) * 1978-04-05 1983-09-08 Syva Co. Label/solid conjugate immunoassay system
US4233402A (en) * 1978-04-05 1980-11-11 Syva Company Reagents and method employing channeling
US4791055A (en) * 1978-04-10 1988-12-13 Miles Inc. Homogenous specific binding assay reagent system and labeled conjugates
US4318980A (en) * 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4492751A (en) * 1978-04-10 1985-01-08 Miles Laboratories, Inc. Heterogenous specific binding assay employing an enzyme substrate as label
US5605800A (en) * 1978-04-13 1997-02-25 Institut Pasteur Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method
FR2422956A1 (en) * 1978-04-13 1979-11-09 Pasteur Institut METHOD OF DETECTION AND CHARACTERIZATION OF A NUCLEIC ACID OR OF A SEQUENCE OF THE SAME, AND ENZYMATIC REAGENT FOR THE IMPLEMENTATION OF THIS PROCESS
US4235969A (en) * 1978-05-08 1980-11-25 Syva Company Procainamide antigen conjugates and antibodies
US4244939A (en) * 1978-06-12 1981-01-13 Baxter Travenol Laboratories, Inc. Barbituric acid tracers and their preparation
US4234681A (en) * 1978-07-21 1980-11-18 The Regents Of The University Of California Immobolized light emitting systems
US4241177A (en) * 1978-08-28 1980-12-23 Syva Company Propanolol antigen conjugates and antibodies
US4239745A (en) * 1978-11-22 1980-12-16 Penicillin Assays, Inc. Antibiotic detection method
WO1980002800A1 (en) * 1979-06-21 1980-12-24 G Oster Specific impending ovulation indicator
US6414152B1 (en) 1981-12-11 2002-07-02 University Of Wales College Of Medicine Of Heath Park Luminescent labelling material and procedures
US4287300A (en) * 1979-07-26 1981-09-01 Syva Company Charge effects in enzyme immunoassays
WO1981001414A1 (en) * 1979-11-19 1981-05-28 Charles Hospital Dev An improved method of non homogenous enzyme immunoassay
US4372745A (en) * 1979-12-19 1983-02-08 Electro-Nucleonics, Inc. Chemical luminescence amplification substrate system for immunochemistry involving microencapsulated fluorescer
US4347312A (en) * 1980-03-20 1982-08-31 Research Triangle Institute Detection of antibiotics in milk
JPS5714748A (en) * 1980-07-01 1982-01-26 Dainippon Pharmaceut Co Ltd Kit for quantitative determination of valproic acid and its method for quantitative determination
EP0057731B1 (en) * 1980-07-11 1984-07-04 Syva Company Valproate derivatives and their conjugates to antigenic materials, antibodies thereto and method for the determination of valproate in physiological fluids
CA1164340A (en) * 1980-09-02 1984-03-27 Alex A. Monte Single test compositions for immunoassays
US4785080A (en) * 1981-03-30 1988-11-15 Baker Instruments Corporation Labeled analytes
US4378458A (en) 1981-03-30 1983-03-29 Baker Instruments Corporation Novel chromogenic and/or fluorogenic substrates for monitoring catalytic or enzymatic activity
US4378428A (en) * 1981-03-30 1983-03-29 Baker Instruments Corporation Method for carrying out non-isotopic immunoassays, labeled analytes and kits for use in such assays
US4608252A (en) * 1981-04-23 1986-08-26 Syntex (U.S.A.) Inc. Chloramphenicol derivatives antigens and antibodies
US4489156A (en) * 1981-04-23 1984-12-18 Syva Company Chloramphenicol derivatives
US4604365A (en) * 1981-06-02 1986-08-05 Electro-Nucleonics, Inc. Immunoprecipitation assay
JPS5818167A (en) * 1981-07-24 1983-02-02 Fuji Photo Film Co Ltd Analyzing film and analysis using said film
US4489157A (en) * 1981-09-28 1984-12-18 Syva Company Chloramphenicol derivatives
DE3279029D1 (en) * 1981-12-11 1988-10-20 Welsh Nat School Med Luminescent labelling materials and procedures
US5103021A (en) * 1982-04-02 1992-04-07 Syntex (U.S.A.) Inc. Acetaminophen analogs, antigens, and antibodies
US4446233A (en) * 1982-05-05 1984-05-01 E. I. Du Pont De Nemours And Company Homogeneous immunoassay using covalent hybrid antibodies
EP0095286B1 (en) * 1982-05-26 1985-12-18 Boots-Celltech Diagnostics Limited Immunoassay
US4472301A (en) * 1982-05-27 1984-09-18 Miles Laboratories, Inc. Propranolol immunogen and antibodies
US4606855A (en) * 1982-07-26 1986-08-19 Mex Research Associates C/O Leon Reimer Monoclonal antibody to digoxin
US4477576A (en) * 1982-07-26 1984-10-16 Mex Research Associates Antigen assay method and kit
US4495281A (en) * 1982-10-21 1985-01-22 Miles Laboratories, Inc. Tricyclic antidepressant drug immunogens, antibodies, labeled conjugates, and related derivatives
US4544629A (en) * 1982-11-19 1985-10-01 Minnesota Mining And Manufacturing Company Receptor-based histamine assay
AU559576B2 (en) * 1983-01-31 1987-03-12 Boots-Celltech Diagnostics Limited Immunoassay
US4614712A (en) * 1983-02-25 1986-09-30 The Upjohn Company Immunoassays with luciferase labeled ligands or receptors
US5089388A (en) * 1983-04-19 1992-02-18 Syntex (U.S.A.) Inc. Antibodies for salicylate and their preparation
US4496479A (en) * 1983-05-18 1985-01-29 Syntex (U.S.A.) Company Chloramphenicol derivatives, antigens and antibodies
US4550075A (en) * 1983-06-22 1985-10-29 Kallestad Laboratories, Inc. Method for ligand determination utilizing an immunoassay monitorable by biotin-containing enzymes, and compositions therefor
US4575485A (en) * 1983-08-29 1986-03-11 Syntex (U.S.A.) Inc. Ultrasonic enhanced immuno-reactions
US4560648A (en) * 1983-09-23 1985-12-24 Syntex (U.S.A.) Inc. Homogeneous enzyme immunoassay for ferritin
JPS61500152A (en) * 1983-10-17 1986-01-30 イノメデイクス・インコ−ポレイテツド Device for rapid quantitative analysis of fluids
US4719176A (en) * 1983-10-31 1988-01-12 Klotz Irving M Enzyme-free diagnostic binding reagents
US4708929A (en) * 1984-10-29 1987-11-24 Microgenics Corporation Methods for protein binding enzyme complementation assays
US4645828A (en) 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US4654311A (en) * 1984-06-15 1987-03-31 Syntex (U.S.A.) Inc. Serum pretreatment for digoxin assay
US4791068A (en) * 1984-06-22 1988-12-13 Scripps Clinic And Research Foundation Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators
AU592324B2 (en) * 1984-10-29 1990-01-11 Roche Diagnostics Corporation Mehods for protein binding enzyme complementation assays
IT1178788B (en) * 1984-12-21 1987-09-16 Sclavo Spa IMMUNOENZYMATIC METHOD FOR THE DETERMINATION OF ANALYTES AND COMPOSITION SUITABLE FOR THE PURPOSE
IE64785B1 (en) 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
US4780409A (en) * 1985-05-02 1988-10-25 Genetic Systems Corporation Thermally induced phase separation immunoassay
DE3683953D1 (en) * 1985-05-31 1992-04-02 Syntex Inc CONJUGATES OF GLUCOSE-6-PHOSPHATE-DEHYDROGENASE, THEIR PRODUCTION AND USE.
US4689397A (en) * 1985-08-12 1987-08-25 Scripps Clinic And Research Foundation Synthetic polypeptides for detecting mycobacterial infections
US5039818A (en) * 1986-02-27 1991-08-13 Syntex (U.S.A.) Inc. Squaraine dye
US4830786A (en) * 1986-02-27 1989-05-16 Syntex (U.S.A.) Inc. Squaraine dyes
US4721704A (en) * 1986-05-09 1988-01-26 Peninsula Laboratories, Inc. Potent synthetic atrial peptide analogs
US4888276A (en) * 1986-06-26 1989-12-19 Minnesota Mining And Manufacturing Company Method and composition for the diagnosis of Lyme disease
US4939264A (en) * 1986-07-14 1990-07-03 Abbott Laboratories Immunoassay for opiate alkaloids and their metabolites; tracers, immunogens and antibodies
US4868132A (en) * 1987-02-03 1989-09-19 Abbott Laboratories Fluorescence polarization immunoassay for amphetamine/methamphetamine
US5241012A (en) 1987-05-19 1993-08-31 Applied Immune Sciences, Inc. Activated and conjugated polystyrene substrate
US6326136B1 (en) 1988-04-01 2001-12-04 Digene Corporation Macromolecular conjugate made using unsaturated aldehydes
US5039607A (en) * 1988-05-17 1991-08-13 Syntex (U.S.A.) Inc. Method for immunochromatographic analysis
US5334513A (en) * 1988-05-17 1994-08-02 Syntex (U.S.A.) Inc. Method for immunochromatographic analysis
US5057430A (en) * 1988-09-15 1991-10-15 Biotronic Systems Corporation Biochemical sensor responsive to bubbles
US5135863A (en) * 1988-12-23 1992-08-04 Syntex (U.S.A.) Inc. Compositions and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
US5939272A (en) * 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5358690A (en) * 1989-01-10 1994-10-25 Lamina, Ltd. Environmental sample collection and membrane testing device
US5028535A (en) * 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5073629A (en) * 1989-01-23 1991-12-17 Abbott Laboratories Methadone fluorescence polarization immunoassay
US5639624A (en) * 1989-03-14 1997-06-17 Board Of Regents Of The University Of Nebraska Monoclonal antibodies specific for metallic cations and method therefor
US5101015A (en) * 1989-04-10 1992-03-31 Abbott Laboratories Reagents for an amphetamine-class fluorescence polarization immunoassay
US5248791A (en) * 1989-04-10 1993-09-28 Abbott Laboratories Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay
CA1335707C (en) * 1989-08-15 1995-05-30 Pyare Khanna Drug screening assay
US5358931A (en) * 1990-01-17 1994-10-25 The Regents Of The University Of California Interaction of thermal hysteresis proteins with cells and cell membranes and associated applications
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
US5532138A (en) * 1990-04-26 1996-07-02 Behringwerke Ag Method and kits for determining peroxidatively active catalysts
US5143852A (en) * 1990-09-14 1992-09-01 Biosite Diagnostics, Inc. Antibodies to ligand analogues and their utility in ligand-receptor assays
US5527686A (en) * 1991-07-29 1996-06-18 Serex, Inc. Differential binding affinities and dissociation assays based thereon
US5279937A (en) * 1992-04-30 1994-01-18 Detechnology Canada Use of macroglobulins to improve the signal-to-background ratio in affinity binding assays
US5273885A (en) * 1992-07-31 1993-12-28 Syntex (U.S.A.) Inc. Conjugates of monophenyl thyroid analogs useful in assays
US5518890A (en) * 1992-11-20 1996-05-21 Mccormick & Company, Inc. Method and apparatus for the quantitation and separation of contaminants from particulate materials
EP0688364A4 (en) * 1993-03-09 1997-10-15 Abbott Lab Genetically engineered enzymes and their conjugates for diagnostic assays
US5869445A (en) * 1993-03-17 1999-02-09 University Of Washington Methods for eliciting or enhancing reactivity to HER-2/neu protein
US6953573B1 (en) * 1993-03-17 2005-10-11 University Of Washington Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US5395752A (en) * 1993-03-19 1995-03-07 Ciba Corning Diagnostics Corp. Long emission wavelength chemiluminescent compounds and their use in test assays
US6455288B1 (en) * 1993-04-08 2002-09-24 Dade Behring Marburg Gmbh Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
US6562333B1 (en) 1993-06-14 2003-05-13 Schering Corporation Purified mammalian CTLA-8 antigens and related reagents
US20040259113A1 (en) * 1993-07-22 2004-12-23 Mayo Foundation For Medical Education And Research, Hybritech Incorporated Method for detection of metastatic prostate cancer
US5516639A (en) * 1993-07-22 1996-05-14 Mayo Foundation For Medical Education And Research Antibodies specific for human prostate glandular kallkrein
US6103237A (en) * 1993-07-22 2000-08-15 Hybritech Incorporated Stable variant hK2 polypeptide
US5684144A (en) * 1993-07-28 1997-11-04 University Of North Texas Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof
US5516647A (en) * 1993-11-05 1996-05-14 Abbott Laboratories Compounds useful as alkaline phosphatase inhibitors and therapeutic agents
US5710009A (en) * 1994-02-17 1998-01-20 Serex, Inc. Receptor:release ligand (reland) complexes and release assays using said reland and methods and kits based thereon
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5856083A (en) * 1994-05-06 1999-01-05 Pharmacopeia, Inc. Lawn assay for compounds that affect enzyme activity or bind to target molecules
WO1995030758A1 (en) * 1994-05-10 1995-11-16 Mayo Foundation For Medical Education And Research Recombinant hk2 polypeptide
ATE201445T1 (en) 1994-08-12 2001-06-15 Myriad Genetics Inc MUTATIONS OF THE OVARIAL AND BREAST CANCER SENSITIVITY GENE LINKED TO 17Q
WO1996005308A1 (en) 1994-08-12 1996-02-22 Myriad Genetics, Inc. Method for diagnosing a predisposition for breast and ovarian cancer
US8236493B2 (en) * 1994-10-21 2012-08-07 Affymetrix, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US6974666B1 (en) * 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US5633149A (en) * 1994-12-07 1997-05-27 Incyte Pharmaceuticals, Inc. Polynucleotide encoding novel chemokine expressed in inflamed adenoid
US7005509B1 (en) 1995-02-17 2006-02-28 Incyte Corporation Chemokine PANEC-1 polynucleotides and compositions and methods related thereto
US5731148A (en) * 1995-06-07 1998-03-24 Gen-Probe Incorporated Adduct protection assay
GB0112226D0 (en) * 2001-05-18 2001-07-11 Danisco Method of improving dough and bread quality
EP0873363B1 (en) 1995-06-14 2010-10-06 The Regents of The University of California High affinity human antibodies to tumor antigens
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US5837492A (en) 1995-12-18 1998-11-17 Myriad Genetics, Inc. Chromosome 13-linked breast cancer susceptibility gene
IL124620A0 (en) 1995-12-18 1998-12-06 Myriad Genetics Inc Chromosome 13-linked breast cancer susceptibility gene
US20040210045A1 (en) * 1996-01-23 2004-10-21 Mcgall Glenn Nucleic acid labeling compounds
US7423143B2 (en) * 1996-01-23 2008-09-09 Affymetrix. Inc. Nucleic acid labeling compounds
US7282327B2 (en) * 1996-01-23 2007-10-16 Affymetrix, Inc. Nucleic acid labeling compounds
US20010018514A1 (en) * 1998-07-31 2001-08-30 Mcgall Glenn H. Nucleic acid labeling compounds
US7468243B2 (en) 2001-03-12 2008-12-23 Affymetrix, Inc. 2-aminopyrimidin-4-one nucleic acid labeling compounds
US6965020B2 (en) 1996-01-23 2005-11-15 Affymetrix, Inc. Nucleic acid labeling compounds
US6864059B2 (en) * 1996-01-23 2005-03-08 Affymetrix, Inc. Biotin containing C-glycoside nucleic acid labeling compounds
US7291463B2 (en) * 1996-01-23 2007-11-06 Affymetrix, Inc. Nucleic acid labeling compounds
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc Nucleic acid analysis techniques
US5808074A (en) * 1996-02-02 1998-09-15 Georgetown University Benzoylecgonine conjugate diagnostic reagents
US6924094B1 (en) 1996-02-08 2005-08-02 Affymetrix, Inc. Chip-based species identification and phenotypic characterization of microorganisms
EP1728875A3 (en) 1996-02-08 2007-05-09 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
JP2000504575A (en) 1996-02-08 2000-04-18 アフィメトリックス，インコーポレイテッド Chip-based speciation and phenotypic characterization of microorganisms
US5882644A (en) * 1996-03-22 1999-03-16 Protein Design Labs, Inc. Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
JP2000507245A (en) * 1996-03-22 2000-06-13 ユニバーシティー オブ ジョージア リサーチ ファウンデーション，インコーポレイテッド Immunogenic compositions and methods comprising Porphyromonas gingivalis peptides
US6942862B2 (en) * 1996-04-01 2005-09-13 University Of Washington Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
JP4124486B2 (en) * 1996-05-22 2008-07-23 ビベンティア バイオテック インコーポレイテッド Antigen binding fragment that specifically detects cancer cells, nucleotides encoding this fragment, and use thereof for cancer prevention and detection
US6342349B1 (en) 1996-07-08 2002-01-29 Burstein Technologies, Inc. Optical disk-based assay devices and methods
US20050214827A1 (en) * 1996-07-08 2005-09-29 Burstein Technologies, Inc. Assay device and method
US6331275B1 (en) 1996-07-08 2001-12-18 Burstein Technologies, Inc. Spatially addressable, cleavable reflective signal elements, assay device and method
EP0918845A4 (en) 1996-07-08 2000-08-30 Burstein Lab Inc Cleavable signal element device and method
JP3706895B2 (en) 1996-07-18 2005-10-19 ベーリングウエルケ、アクティエンゲゼルシャフト Reagent for ligand assay
ES2203815T3 (en) * 1996-07-18 2004-04-16 Dade Behring Marburg Gmbh REAGENTS FOR ANALYSIS OF MYCOPHENOLIC ACID.
DE69738749D1 (en) 1996-08-16 2008-07-17 Schering Corp CELL SURFACE ANTIGEN FROM MAMMALS AND RELATED REAGENTS
EP0932678B2 (en) 1996-09-24 2010-03-10 Genentech, Inc. A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
US20070299005A1 (en) * 1996-09-24 2007-12-27 Tanox, Inc. Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
US7585622B1 (en) 1996-10-01 2009-09-08 Geron Corporation Increasing the proliferative capacity of cells using telomerase reverse transcriptase
US6261836B1 (en) 1996-10-01 2001-07-17 Geron Corporation Telomerase
US6808880B2 (en) * 1996-10-01 2004-10-26 Geron Corporation Method for detecting polynucleotides encoding telomerase
US6475789B1 (en) * 1996-10-01 2002-11-05 University Technology Corporation Human telomerase catalytic subunit: diagnostic and therapeutic methods
US6093809A (en) 1996-10-01 2000-07-25 University Technology Corporation Telomerase
US6610839B1 (en) 1997-08-14 2003-08-26 Geron Corporation Promoter for telomerase reverse transcriptase
KR20000048820A (en) 1996-10-01 2000-07-25 게론 코포레이션 Telomerase reverse transcriptase
GB9907461D0 (en) 1999-03-31 1999-05-26 King S College London Neurite regeneration
US6479263B1 (en) 1996-11-14 2002-11-12 Baylor College Of Medicine Method for detection of micrometastatic prostate cancer
PT1114864E (en) 1996-12-13 2008-10-08 Schering Corp Mammalian cell surface antigens, related reagents
ATE443141T1 (en) 1997-02-07 2009-10-15 Us Gov Health & Human Serv ACTIVITY DEPENDENT NEUROTROPIC FACTOR III (ADNF III)
KR100509438B1 (en) * 1997-04-01 2005-08-23 테라코스, 인코포레이티드 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
US7622549B2 (en) * 1997-04-18 2009-11-24 Geron Corporation Human telomerase reverse transcriptase polypeptides
US20050013825A1 (en) * 1997-04-18 2005-01-20 Geron Corporation Vaccine containing the catalytic subunit of telomerase for treating cancer
US7413864B2 (en) * 1997-04-18 2008-08-19 Geron Corporation Treating cancer using a telomerase vaccine
IL132614A0 (en) 1997-05-07 2001-03-19 Schering Corp Human toll-like receptor proteins related reagents and methods
DE69831229T2 (en) * 1997-05-14 2006-04-13 Biosite Diagnostics Inc., San Diego FAST DETERMINATION OF THE RELATIONSHIP OF BIOLOGICAL MOLECULES
US7115722B1 (en) 1997-05-22 2006-10-03 Viventia Biotech, Inc. Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
US6235486B1 (en) 1997-06-20 2001-05-22 Mayo Foundation For Medical Education & Research Method for detection of breast cancer
US20020122807A1 (en) * 1998-07-07 2002-09-05 Dan Michael D. Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
KR20010021597A (en) 1997-07-09 2001-03-15 둘락 노먼 씨. Isolated dendritic cell membrane protein genes
JP2001500391A (en) * 1997-07-11 2001-01-16 ユニバーシティ オブ ノース テキサス Escherichia coli csrB gene, RNA encoded thereby, and methods of use
US6762039B2 (en) * 1997-07-15 2004-07-13 Genencor International, Inc. Bacillus subtillis with an inactivated cysteine protease-1
US6723550B1 (en) * 1997-07-15 2004-04-20 Genencor International, Inc. Proteases from gram-positive organisms
US6506579B1 (en) 1997-07-15 2003-01-14 Genencor International, Inc. Increasing production of proteins in gram-positive microorganisms using SecG
US20030157642A1 (en) * 1997-07-15 2003-08-21 Caldwell Robert M. Increasing production of proteins in gram-positive microorganisms
US6521421B1 (en) * 1997-07-16 2003-02-18 Genencor International, Inc. Expression vectors encoding Bacillus subtilis disulfide bond isomerase and methods of secreting proteins in gram-positive microorganisms using the same
CO4810232A1 (en) 1997-07-25 1999-06-30 Schering Corp MAMMALIAN CYTOKINES AND THEIR CODING SEQUENCES
PT1003861E (en) 1997-08-01 2007-01-31 Schering Corp Mammalian cell membrane proteins; related reagents
US6180411B1 (en) 1997-08-01 2001-01-30 The Regents Of The University Of California Light-triggered indicators that memorize analyte concentrations
US5929049A (en) 1997-08-08 1999-07-27 Dade Behring Marburg Gmbh Polysaccharide conjugates of biomolecules
US7252950B1 (en) * 1997-09-04 2007-08-07 The Regents Of The University Of California Assays for detecting modulators of cytoskeletal function
US6521440B1 (en) * 1997-09-15 2003-02-18 Genencor International, Inc. Proteases from gram-positive organisms
US6300117B1 (en) * 1997-09-15 2001-10-09 Genencor International, Inc. Proteases from gram-positive organisms
US7378244B2 (en) * 1997-10-01 2008-05-27 Geron Corporation Telomerase promoters sequences for screening telomerase modulators
GB9724629D0 (en) * 1997-11-20 1998-01-21 Genencor Int Bv Alpha/beta hydrolase-fold enzymes
GB9724627D0 (en) 1997-11-20 1998-01-21 Genencor Int Bv Gram positive microorganism formate pathway
US6316241B1 (en) * 1997-11-20 2001-11-13 Genencor International, Inc. Alpha/beta hydrolase-fold enzymes
US6528255B1 (en) * 1997-12-30 2003-03-04 Genencor International, Inc. Proteases from gram positive organisms
US6599731B1 (en) 1997-12-30 2003-07-29 Genencor International, Inc. Proteases from gram positive organisms
US6465186B1 (en) * 1997-12-30 2002-10-15 Genecor International, Inc. Proteases from gram positive organisms
GB9727470D0 (en) * 1997-12-30 1998-02-25 Genencor Int Bv Proteases from gram positive organisms
US6780609B1 (en) 1998-10-23 2004-08-24 Genome Therapeutics Corporation High bone mass gene of 1.1q13.3
US6759243B2 (en) 1998-01-20 2004-07-06 Board Of Trustees Of The University Of Illinois High affinity TCR proteins and methods
US6673914B1 (en) 1998-01-22 2004-01-06 John Wayne Cancer Institute Human tumor-associated gene
US6060260A (en) * 1998-02-27 2000-05-09 Dade Behring Inc. Methods for reducing adsorption in an assay
JP2002505108A (en) 1998-03-04 2002-02-19 ジェネンコア インターナショナル インコーポレーテッド Modified form of pullulanase
US6869770B1 (en) 1998-03-20 2005-03-22 The Curators Of The University Of Missouri Compositions and methods for early pregnancy diagnosis
US6303081B1 (en) * 1998-03-30 2001-10-16 Orasure Technologies, Inc. Device for collection and assay of oral fluids
EP1086372B1 (en) 1998-03-30 2006-05-31 OraSure Technologies, Inc. Collection device for single step assay of oral fluids
US8062908B2 (en) * 1999-03-29 2011-11-22 Orasure Technologies, Inc. Device for collection and assay of oral fluids
AU3217599A (en) * 1998-03-31 1999-10-18 Genzyme Corporation Methods for the diagnosis and treatment of lung cancer
US6337200B1 (en) * 1998-03-31 2002-01-08 Geron Corporation Human telomerase catalytic subunit variants
US7108968B2 (en) * 1998-04-03 2006-09-19 Affymetrix, Inc. Mycobacterial rpoB sequences
US6872537B1 (en) 1998-04-14 2005-03-29 Regents Of The University Of California Assays for the detection of microtubule depolymerization inhibitors
JP2002522747A (en) 1998-04-14 2002-07-23 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Assays for detecting microtubule depolymerization inhibitors
US6699969B1 (en) 1998-04-14 2004-03-02 The Regents Of The University Of California Assays for the detection of microtubule depolymerization inhibitors
US6153442A (en) * 1998-05-20 2000-11-28 Dade Behring Inc. Reagents and methods for specific binding assays
US6303325B1 (en) 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes
WO1999064447A1 (en) * 1998-06-09 1999-12-16 Immco Diagnostics Solution-phase elisa
US6171802B1 (en) * 1998-06-10 2001-01-09 Kent State University Detection and amplification of ligands
DE69904941T3 (en) 1998-07-21 2008-01-31 Danisco A/S FOOD
CA2338401A1 (en) * 1998-07-21 2000-02-03 Burstein Laboratories, Inc Optical disc-based assay devices and methods
US6187563B1 (en) 1998-08-07 2001-02-13 Yale University βIV-spectrin-polypeptides and nucleic acids encoding same
SE9803099D0 (en) 1998-09-13 1998-09-13 Karolinska Innovations Ab Nucleic acid transfer
EP1897949B1 (en) 1998-09-21 2014-11-12 Merck Sharp & Dohme Corp. Human interleukin-B50. Therapeutic uses
EP0997476A3 (en) 1998-09-25 2000-07-19 Schering-Plough Antibodies to a mammalian Langerhans cell antigen and their uses
AU770807B2 (en) 1999-01-11 2004-03-04 Merck Sharp & Dohme Corp. Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
US6156515A (en) * 1999-02-09 2000-12-05 Urocor, Inc. Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
US7025961B1 (en) 1999-03-04 2006-04-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-plasmodium composition and methods of use
AR022890A1 (en) 1999-03-11 2002-09-04 Schering Corp MAMMARY CYTOKINS; RELATED REAGENTS AND METHODS
CA2372549A1 (en) 1999-05-13 2000-11-23 Medical Research Council Ox2 receptor homologs
WO2000069898A2 (en) 1999-05-14 2000-11-23 Arbor Vita Corporation Molecular interactions in allergy cells
EP1181366B2 (en) 1999-06-01 2013-08-21 Merck Sharp & Dohme Corp. Mammalian receptor proteins; related reagents and methods
GB9914210D0 (en) 1999-06-17 1999-08-18 Danisco Promoter
US6262265B1 (en) 1999-06-18 2001-07-17 Microgenics Corporation Non-hydrolyzable analogs of heroin metabolites suitable for use in immunoassay
US6531130B1 (en) * 1999-07-06 2003-03-11 The Board Of Trustees Of The Leland Stanford University Treatment of demyelinating autoimmune disease with ordered peptides
CA2376955A1 (en) 1999-07-06 2001-01-11 Surromed, Inc. Bridged fluorescent dyes, their preparation and their use in assays
MXPA02001146A (en) 1999-07-30 2002-08-20 Schering Corp Mammalian cytokines; related reagents.
US7078495B1 (en) 1999-08-03 2006-07-18 Dade Behring Inc. Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus
EP1905832A3 (en) 1999-09-09 2009-09-09 Schering Corporation Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions
US7668658B2 (en) 1999-10-13 2010-02-23 Sequenom, Inc. Methods for generating databases and databases for identifying polymorphic genetic markers
US7030228B1 (en) 1999-11-15 2006-04-18 Miltenyi Biotec Gmbh Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
MXPA02005199A (en) 1999-11-24 2002-11-07 Schering Corp Methods of inhibiting metastasis.
DE60040556D1 (en) 1999-12-06 2008-11-27 Univ Illinois HIGH-AFFINE T-CELL RECEPTOR PROTEINS AND METHOD
US6544792B1 (en) * 1999-12-21 2003-04-08 Genencor International, Inc. Production of secreted polypeptides
US7166719B2 (en) 2002-06-27 2007-01-23 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
AU2001227837A1 (en) 2000-01-12 2001-07-24 Light Sciences Corporation Novel treatment for eye disease
DE10003734A1 (en) * 2000-01-28 2001-08-02 Bosch Gmbh Robert Detection method and device
DE60131146T2 (en) * 2000-02-25 2008-03-06 Ludwig Institute For Cancer Research MATERIALS AND METHODS CONTAINING HYBRID VASCULAR ENDOTHELIC GROWTH FACTORS DNA AND PROTEINS AND SCREENING METHOD FOR MODULATORS
US8288128B2 (en) * 2004-11-18 2012-10-16 Eppendorf Array Technologies S.A. Real-time quantification of multiple targets on a micro-array
US7875442B2 (en) * 2000-03-24 2011-01-25 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
US7829313B2 (en) * 2000-03-24 2010-11-09 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
US20030108927A1 (en) * 2000-04-03 2003-06-12 Kathryn Leishman Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
EP2020239A1 (en) 2000-04-18 2009-02-04 Schering Corporation Use of IL-174 agonists for treating infectious diseases
EP1305632B1 (en) 2000-05-04 2011-07-27 Siemens Healthcare Diagnostics Products GmbH Methods for detection of multiple analytes
US7422743B2 (en) 2000-05-10 2008-09-09 Schering Corporation Mammalian receptor protein DCRS5;methods of treatment
JP5073909B2 (en) 2000-05-10 2012-11-14 メルク・シャープ・アンド・ドーム・コーポレーション Mammalian receptor proteins; related reagents and methods
EP1908837A3 (en) 2000-05-25 2008-06-11 Schering Corporation Human receptor proteins, related reagents and methods
WO2005000087A2 (en) * 2003-06-03 2005-01-06 Chiron Corporation Gene products differentially expressed in cancerous colon cells and their methods of use ii
US6958214B2 (en) 2000-07-10 2005-10-25 Sequenom, Inc. Polymorphic kinase anchor proteins and nucleic acids encoding the same
GR1004119B (en) * 2000-07-26 2003-01-23 Αυτοματοι Αναλυτες Και Διαγνωστικα Αντιδραστηρια Medicon Hellas Α.Ε. DEVELOPMENT OF A NEW HOMOGENEOUS IMMUNOENZYMIC METHOD FOR THE PRODUCTION OF A CLINICAL LABORATORY TEST SYSTEM (kit) FOR THE QUANTIFICATION OF THYROXINE AND TRIIODOTHYRONINE IN HUMAN SERUM, UTILIZINGPOLYIODOTHYRONINE CONJUGATED WITH GLYCOGEN PHOSPHO....
WO2002011756A2 (en) * 2000-08-07 2002-02-14 Entremed, Inc. Anti-plasmodium compositions and methods of use
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
JP2004515751A (en) 2000-09-08 2004-05-27 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム Methods and compositions for in vitro targeting
ATE549347T1 (en) 2000-09-08 2012-03-15 Schering Corp MAMMAL GENES, AND ASSOCIATED REAGENTS, METHODS
US6673623B1 (en) 2000-09-12 2004-01-06 Novocure, Inc. Methods and compositions that control lipid production
AU2001292749A1 (en) * 2000-09-18 2002-03-26 Genencor International, Inc. Twin-arginine translocation in bacillus
US7045283B2 (en) 2000-10-18 2006-05-16 The Regents Of The University Of California Methods of high-throughput screening for internalizing antibodies
US6890734B2 (en) 2000-11-10 2005-05-10 Schering Corporation Nucleic acids encoding a cytokine receptor complex
US20040248093A1 (en) * 2000-11-27 2004-12-09 Coombs James Howard Magneto-optical bio-discs and systems including related methods
US20020172980A1 (en) * 2000-11-27 2002-11-21 Phan Brigitte Chau Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
US20030003464A1 (en) * 2000-11-27 2003-01-02 Phan Brigitte C. Dual bead assays including optical biodiscs and methods relating thereto
US20030054446A1 (en) * 2000-11-29 2003-03-20 Weber Bernard H. F. Novel retina-specific human proteins C7orf9, C12orf7, MPP4 and F379
AU2002220275A1 (en) * 2000-12-08 2002-06-18 The Board Of Trustees Of The University Of Illinois Mutated class ii major histocompatibility proteins
US7087395B1 (en) 2001-01-16 2006-08-08 Quest Diagnostics Investments Incorporated Vitamin D assay
GB0101762D0 (en) * 2001-01-23 2001-03-07 Medical Res Council Method
US20030104410A1 (en) * 2001-03-16 2003-06-05 Affymetrix, Inc. Human microarray
US20030220475A1 (en) * 2001-04-03 2003-11-27 Fields Howard A. Neutralizing immunogenic hev polypepetides
WO2002081630A2 (en) * 2001-04-06 2002-10-17 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of semenogelin in the diagnosis, prognosis and treatment of cancer
NZ528260A (en) 2001-05-18 2005-09-30 Danisco Method of improving dough and bread quality with the addition of an enzyme that hydrolyses a glycolipid and a phospholipid and incapable of hydrolysing a triglyceride or monoglyceride
ATE413884T1 (en) 2001-05-22 2008-11-15 Merck & Co Inc BETA-SECRETASE SUBSTRATE AND USE THEREOF
US20070190534A1 (en) * 2001-06-11 2007-08-16 Genesis Genomics Inc. Mitochondrial sites and genes associated with prostate cancer
DE60237696D1 (en) * 2001-08-01 2010-10-28 Univ Utah AT N-TERMINUS TRUNCATED ISOFORMS OF CYCLIC PHOSPHODIESTERASES PDE3A
US6833441B2 (en) * 2001-08-01 2004-12-21 Abmaxis, Inc. Compositions and methods for generating chimeric heteromultimers
US20030082596A1 (en) * 2001-08-08 2003-05-01 Michael Mittmann Methods of genetic analysis of probes: test3
US20060073530A1 (en) * 2001-08-15 2006-04-06 Olaf Schneewind Methods and compositions involving sortase B
US7166208B2 (en) * 2004-03-03 2007-01-23 Stephen Eliot Zweig Apoenzyme reactivation electrochemical detection method and assay
US8118991B2 (en) * 2001-09-04 2012-02-21 Stephen Eliot Zweig Apoenzyme reactivation electrochemical detection method and assay
EP2131198B1 (en) 2001-09-20 2013-03-27 Board of Regents, The University of Texas System Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
WO2003028582A2 (en) 2001-09-28 2003-04-10 Aspenbio, Inc. Bovine pregnancy test
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
US7138370B2 (en) 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
US20030077282A1 (en) 2001-10-12 2003-04-24 Bigler Michael Eric Use of bispecific antibodies to regulate immune responses
US20030170678A1 (en) * 2001-10-25 2003-09-11 Neurogenetics, Inc. Genetic markers for Alzheimer's disease and methods using the same
US20030224380A1 (en) * 2001-10-25 2003-12-04 The General Hospital Corporation Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseases
WO2003054143A2 (en) * 2001-10-25 2003-07-03 Neurogenetics, Inc. Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
US7175983B2 (en) * 2001-11-02 2007-02-13 Abmaxis, Inc. Adapter-directed display systems
MXPA04004880A (en) 2001-11-20 2004-09-03 Monsanto Technology Llc Compositions and methods for accurate early pregnancy diagnosis.
US6696254B2 (en) 2001-11-21 2004-02-24 Kimberly-Clark Worldwide, Inc. Detection and identification of enteric bacteria
US6952704B2 (en) * 2001-11-26 2005-10-04 Microsoft Corporation Extending a directory schema independent of schema modification
US9575070B2 (en) * 2001-12-04 2017-02-21 Wayne State University Neoepitope detection of disease using protein arrays
NZ533987A (en) 2002-02-01 2007-04-27 Schering Corp Uses of mammalian cytokine; agonists and antagonists for modulating antigen presenting cell priming of T cells
SI3031910T1 (en) 2002-02-21 2018-05-31 Institute Of Virology Slovak Academy Of Sciences Mn/ca ix-specific monoclonal antibodies generated from mn/ca ix-deficient mice and methods of use
EP1573035B1 (en) 2002-02-22 2015-09-02 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Brother of the regulator of imprinted sites (boris)
US7053188B2 (en) 2002-02-22 2006-05-30 Purdue Research Foundation Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
US7872048B2 (en) 2004-09-18 2011-01-18 University Of Maryland, Baltimore Methods for treating spinal cord injury with a compound that inhibits a NCCa-ATP channel
US7332585B2 (en) 2002-04-05 2008-02-19 The Regents Of The California University Bispecific single chain Fv antibody molecules and methods of use thereof
WO2003089659A1 (en) * 2002-04-16 2003-10-30 The Regents Of The University Of California Methods or renal cell carcinoma prognosis and treatment selection with carbonic anhydrase ix
US7534580B2 (en) * 2002-05-01 2009-05-19 Ambrilia Biopharma Inc. PSP94 diagnostic reagents and assays
CA2391438A1 (en) * 2002-05-01 2003-11-01 Procyon Biopharma Inc. Psp94 diagnostic reagents and assays
WO2003093493A2 (en) * 2002-05-02 2003-11-13 Aspenbio, Inc. Pregnancy detection
CA2484676A1 (en) 2002-05-03 2003-11-13 Sequenom, Inc. Kinase anchor protein muteins, peptides thereof, and related methods
CA2492631C (en) * 2002-05-31 2013-03-12 Genetic Technologies Limited Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
US7560239B2 (en) * 2002-06-04 2009-07-14 Lin-Zhi International Inc. Homogeneous enzyme immunoassay for simultaneous detection of multiple analytes
EP2036908A3 (en) * 2002-07-02 2009-05-13 Health Research, INC. Efficient synthesis of pyropheophorbide a derivates
US7504215B2 (en) 2002-07-12 2009-03-17 Affymetrix, Inc. Nucleic acid labeling methods
EP2269656B1 (en) 2002-07-15 2014-08-20 Board Of Regents, The University Of Texas Selected antibodies binding to aminophospholipids and their use in treatment, such as cancer
US6916474B2 (en) 2002-07-15 2005-07-12 Board Of Regents, The University Of Texas System Antibodies with increased affinities for anthrax antigens
US7794716B2 (en) 2002-07-25 2010-09-14 Glenveigh Pharmaceuticals, Llc Antibody composition and passive immunization against pregnancy-induced hypertension
AU2003264033A1 (en) 2002-08-10 2004-02-25 Biogen Idec Ma Inc. Nogo receptor antagonists
CA2533915C (en) 2002-08-13 2020-09-22 N-Dia, Inc. Devices and methods for detecting amniotic fluid in vaginal secretions
JP4694840B2 (en) 2002-09-09 2011-06-08 アルボー ビータ コーポレーション How to test for cervical cancer
ATE445165T1 (en) * 2002-10-21 2009-10-15 Discoverx Corp IP3 PROTEIN BINDING TEST
MXPA05004434A (en) 2002-10-24 2005-07-26 Sterix Ltd Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2.
US20060198817A1 (en) 2002-11-26 2006-09-07 Alverdy John C Materials and methods for preventing and treating microbe-mediated epithelial disorders
AU2003298706A1 (en) 2002-12-04 2004-06-23 Applera Corporation Multiplex amplification of polynucleotides
US20040229245A1 (en) * 2003-01-06 2004-11-18 Anton Bittner Methods and algorithms for performing quality control during gene expression profiling on DNA microarray technology
US7955814B2 (en) * 2003-01-17 2011-06-07 Danisco A/S Method
DK1762622T3 (en) 2003-01-17 2012-01-16 Danisco Process for the in situ production of an emulsifier in a foodstuff
US20050196766A1 (en) * 2003-12-24 2005-09-08 Soe Jorn B. Proteins
MXPA05007654A (en) * 2003-01-17 2005-09-30 Danisco Method.
JP2007501407A (en) * 2003-03-03 2007-01-25 長岡実業株式会社 Methods and apparatus used for the detection and quantification of various cell types and the use of optical biodiscs to do this
WO2004078999A1 (en) * 2003-03-05 2004-09-16 Genetic Technologies Limited Identification of fetal dna and fetal cell markers in maternal plasma or serum
US20070141570A1 (en) * 2003-03-07 2007-06-21 Sequenom, Inc. Association of polymorphic kinase anchor proteins with cardiac phenotypes and related methods
ES2360291T3 (en) 2003-03-07 2011-06-02 New England Medical Center Hospitals, Inc. TREATMENT OF DISEASES BY DEPOSITION OF IgA1.
US20050003147A1 (en) * 2003-03-24 2005-01-06 Anderson-Tully Engineered Wood Llc Laminated board and methods of producing the same
ES2369498T3 (en) 2003-04-04 2011-12-01 Yeda Research And Development Co., Ltd. ANTIBODIES TO INHIBIT THE ACTIVITY OF MMP-2 AND MMP-9.
JP2006523708A (en) * 2003-04-16 2006-10-19 イェール ユニバーシティ Nogo receptor antagonist for the treatment of conditions associated with amyloid plaques
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof
US7057100B2 (en) * 2003-06-26 2006-06-06 The J.C. Robinson Seed Co. Inbred corn line W23129
US20070041971A1 (en) * 2003-07-07 2007-02-22 Wagner David H Methods for predicting development of auto-immune diseases and treatment of same
ES2378544T3 (en) * 2003-07-08 2012-04-13 Accumetrics, Inc. Selective platelet activation for follow-up therapy with ADP antagonists
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
AU2004263896A1 (en) 2003-08-08 2005-02-17 Genenews Inc. Osteoarthritis biomarkers and uses thereof
US20050064479A1 (en) * 2003-08-12 2005-03-24 Affymetrix, Inc. Compounds and methods for post incorporation labeling of nucleic acids
JP2007502119A (en) 2003-08-14 2007-02-08 エクセリクシス， インク． UPs as β-catenin pathway modifiers and methods of use
CA2537736A1 (en) * 2003-09-04 2005-03-17 Technion Research And Development Foundation Ltd. Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compounds and uses thereof
EP2280285A1 (en) 2003-09-15 2011-02-02 Oklahoma Medical Research Foundation Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases
US20050064435A1 (en) * 2003-09-24 2005-03-24 Xing Su Programmable molecular barcodes
US20050227251A1 (en) 2003-10-23 2005-10-13 Robert Darnell Method of purifying RNA binding protein-RNA complexes
PT1680141E (en) 2003-11-04 2010-12-20 Novartis Vaccines & Diagnostic Methods of therapy for solid tumors expressing the cd40 cell-surface antigen
EP2243492A1 (en) 2003-11-04 2010-10-27 Novartis Vaccines and Diagnostics, Inc. Use of antagonist anti-cd40 monoclonal antibodies for treatment of multiple myeloma
PT1682177E (en) 2003-11-04 2010-11-29 Xoma Technology Lt Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia
EP1682178B8 (en) 2003-11-04 2010-09-01 Novartis Vaccines and Diagnostics, Inc. Methods of therapy for cancers expressing the cd40 antigen
PE20050925A1 (en) 2003-11-10 2005-11-29 Schering Corp RECOMBINANT ANTI-INTERLEUQUIN HUMANIZED ANTIBODY 10
JP3615752B1 (en) 2003-11-18 2005-02-02 淳 高橋 Small diameter resin twist brush
US6991911B2 (en) 2003-12-15 2006-01-31 Dade Behring Inc. Assay for entactogens
US7022492B2 (en) 2003-12-15 2006-04-04 Dade Behring Inc. Ecstasy haptens and immunogens
CA2551560A1 (en) 2003-12-23 2005-07-14 Arbor Vita Corporation Antibodies for oncogenic strains of hpv and methods of their use
EP1704236B1 (en) 2003-12-24 2017-11-29 DuPont Nutrition Biosciences ApS Proteins
GB0716126D0 (en) * 2007-08-17 2007-09-26 Danisco Process
US7718408B2 (en) * 2003-12-24 2010-05-18 Danisco A/S Method
US20050186646A1 (en) * 2004-01-26 2005-08-25 Cruz Miguel A. Rapid assay to detect ADAMTS-13 activity
US20070178462A1 (en) * 2004-02-18 2007-08-02 Uebele Victor N Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha1h, encoded proteins and methods of use thereof
GB0403864D0 (en) 2004-02-20 2004-03-24 Ucl Ventures Modulator
EP2208797A3 (en) 2004-03-01 2010-11-24 Applied Biosystems, LLC Methods, compositions and kits for use in polynucleotide amplification
GB0405637D0 (en) 2004-03-12 2004-04-21 Danisco Protein
WO2006073430A2 (en) * 2004-04-20 2006-07-13 The University Of Chicago Therapeutic delivery system comprising a high molecular weight peg-like compound
US8586294B2 (en) 2004-05-18 2013-11-19 The Board Of Trustees Of The Leland Stanford Junior University Detection of protein translocation by beta-galactosidase reporter fragment complementation
EP1753871B1 (en) 2004-05-28 2015-07-15 Agensys, Inc. Antibodies and related molecules that bind to psca proteins
US8034553B2 (en) 2004-06-24 2011-10-11 Kimberly-Clark Worldwide, Inc. Biomarkers for wound healing
EP1766397B1 (en) * 2004-06-30 2016-03-09 DiscoveRx Corporation Analysis of intracellular modifications
ATE514767T1 (en) * 2004-07-16 2011-07-15 Danisco ENZYMATIC OIL GUMBERING PROCESS
US20090035784A1 (en) * 2004-07-30 2009-02-05 Mount Sinai School Of Medicine Of New York University Npc1l1 and npc1l1 inhibitors and methods of use thereof
US20060073168A1 (en) * 2004-08-11 2006-04-06 Stephens David S Neisseria meningitidis serogroup a capsular polysaccharide acetyltransferase, methods and compositions
EP1791959A4 (en) 2004-08-26 2009-03-18 Enegenic Gene Therapy Pty Ltd Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells
US20060046273A1 (en) * 2004-08-27 2006-03-02 Lin-Zhi International Inc. Homogeneous enzyme immunoassay for oral fluid
FI20050753A (en) 2004-09-03 2006-03-04 Licentia Oy New peptides
DE602005021525D1 (en) 2004-09-14 2010-07-08 Univ Colorado R TREATMENT WITH BUCINDOLOL
AU2005290238A1 (en) 2004-09-18 2006-04-06 Department Of Veterans Affairs Therapeutic agents trageting the NCCa-ATP channel and methods of use thereof
ES2629397T3 (en) * 2004-09-24 2017-08-09 Amgen Inc. Modified Fc molecules
GB0422052D0 (en) 2004-10-04 2004-11-03 Dansico As Enzymes
US7390489B2 (en) * 2004-10-08 2008-06-24 Komed Co., Ltd. Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the antibody
GB0423139D0 (en) 2004-10-18 2004-11-17 Danisco Enzymes
JP5525689B2 (en) * 2004-11-02 2014-06-18 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ セクレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ Compositions and methods for treating hyperproliferative disorders
US20090118132A1 (en) * 2004-11-04 2009-05-07 Roche Molecular Systems, Inc. Classification of Acute Myeloid Leukemia
GB0424940D0 (en) 2004-11-11 2004-12-15 Danisco Transcription factors
WO2006055635A2 (en) * 2004-11-15 2006-05-26 Mount Sinai School Of Medicine Of New York University Compositions and methods for altering wnt autocrine signaling
EP2302072B1 (en) 2004-11-18 2012-03-14 Eppendorf Array Technologies S.A. Real time-PCR of targets on a micro-array
WO2006060419A2 (en) 2004-12-03 2006-06-08 Schering Corporation Biomarkers for pre-selection of patients for anti-igf1r therapy
US7504769B2 (en) * 2004-12-16 2009-03-17 E. I. Du Pont De Nemours + Company Aromatic chalcogen compounds and their use
US7842794B2 (en) 2004-12-17 2010-11-30 Roche Molecular Systems, Inc. Reagents and methods for detecting Neisseria gonorrhoeae
US8697674B2 (en) 2004-12-29 2014-04-15 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
US7713695B2 (en) 2005-02-07 2010-05-11 Genenews, Inc. Mild osteoarthritis biomarkers and uses thereof
GB0503546D0 (en) * 2005-02-21 2005-03-30 Hellenic Pasteur Inst Antibody
CA2603093A1 (en) 2005-03-31 2006-10-05 Agensys, Inc. Antibodies and related molecules that bind to 161p2f10b proteins
PL2645106T3 (en) 2005-04-04 2017-11-30 Biogen Ma Inc. Methods for evaluating an immune response to a therapeutic agent
US20130022979A1 (en) 2005-04-18 2013-01-24 Genesis Genomics Inc. 3.4kb MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER
CN103789405B (en) 2005-04-18 2018-03-30 Mdna生命科学有限公司 Mitochondrial mutations and rearrangement as the diagnostic tool of detection solar radiation, prostate cancer and other cancers
US20060240496A1 (en) * 2005-04-21 2006-10-26 Lakshmi Anne Immunogens, derivatives and immunoassay for ethyl glucuronide
US7189582B2 (en) 2005-04-27 2007-03-13 Dade Behring Inc. Compositions and methods for detection of sirolimus
WO2006125117A2 (en) 2005-05-18 2006-11-23 Novartis Ag Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component
US20070021433A1 (en) 2005-06-03 2007-01-25 Jian-Qiang Fan Pharmacological chaperones for treating obesity
US7709198B2 (en) 2005-06-20 2010-05-04 Advanced Cell Diagnostics, Inc. Multiplex detection of nucleic acids
US7695975B2 (en) 2005-06-23 2010-04-13 Siemens Healthcare Diagnostics Inc. Detection of adulterated samples
JP2009504659A (en) * 2005-08-08 2009-02-05 オンコノン・リミテッド・ライアビリティ・カンパニー Antibody composition, method of treating neoplastic disease, and method of modulating fertility
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
ES2619845T3 (en) 2005-08-31 2017-06-27 Merck Sharp & Dohme Corp. Anti-IL-23 antibodies engineered by genetic engineering
US7608395B2 (en) * 2005-09-15 2009-10-27 Baylor Research Institute Systemic lupus erythematosus diagnostic assay
WO2007041340A2 (en) * 2005-09-30 2007-04-12 The Trustees Of Columbia University In The City Of New York Microfluidic cells with parallel arrays of individual dna molecules
US20070202515A1 (en) * 2005-10-12 2007-08-30 Pathologica, Llc. Promac signature application
US8249814B2 (en) 2005-10-21 2012-08-21 Genenews Inc. Method, computer readable medium, and system for determining a probability of colorectal cancer in a test subject
CN101500592A (en) 2005-11-07 2009-08-05 斯克利普斯研究院 Compositions and methods for controlling tissue factor signaling specificity
US8124351B2 (en) 2005-11-18 2012-02-28 Board Of Regents, The University Of Texas System Quantification of fusion proteins and their activity from chromosomal translocation
US8158360B2 (en) 2005-12-08 2012-04-17 Novartis Ag Effects of inhibitors of FGFR3 on gene transcription
US20070134814A1 (en) * 2005-12-09 2007-06-14 Kajander E O Methods and compositions for the detection of calcifying nano-particles, identification and quantification of associated proteins thereon, and correlation to disease
EP2674440B1 (en) 2005-12-16 2019-07-03 IBC Pharmaceuticals, Inc. Multivalent immunoglobulin-based bioactive assemblies
WO2007071448A2 (en) 2005-12-23 2007-06-28 Partnership & Corp. Technology Transfer Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation
US7465544B2 (en) * 2006-01-11 2008-12-16 Wisconsin Alumni Research Foundation Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use
PT1981902E (en) 2006-01-27 2015-11-02 Biogen Ma Inc Nogo receptor antagonists
DOP2007000020A (en) 2006-01-31 2007-09-15 Bayer Schering Pharma Ag MODULATION OF THE ACTIVITY OF MDL-1 FOR THE TREATMENT OF INFLAMMATORY DISEASES
AR059371A1 (en) 2006-02-08 2008-03-26 Genzyme Corp GENE THERAPY FOR NIEMANN-PICK TYPE A DISEASE
DE102006009516B4 (en) * 2006-02-28 2007-12-06 Analyticon Biotechnologies Ag Test device, manufacturing method therefor and test method
HUE047230T2 (en) 2006-02-28 2020-04-28 Biogen Ma Inc Methods of treating inflammatory and autoimmune diseases with natalizumab
US20070231319A1 (en) 2006-03-03 2007-10-04 Yednock Theodore A Methods of treating inflammatory and autoimmune diseases with natalizumab
WO2007109733A2 (en) 2006-03-21 2007-09-27 The Johns Hopkins University Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
US20070232556A1 (en) * 2006-03-31 2007-10-04 Montine Thomas J Methods and compositions for the treatment of neurological diseases and disorders
KR20090029184A (en) * 2006-04-07 2009-03-20 더 가브먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 Antibody compositions and methods for treatment of neoplastic disease
NZ571757A (en) 2006-04-21 2012-01-12 Novartis Ag Antagonist anti-CD40 antibody pharmaceutical compositions comprising arginine-HCl and a citrate or citric acid buffer
FR2900341B1 (en) * 2006-04-27 2012-09-14 Centre Nat Rech Scient USE OF MULTIVALENT SYNTHETIC LIGANDS OF SURFACE NUCLEOLIN FOR THE TREATMENT OF CANCER
US7799534B2 (en) * 2006-05-09 2010-09-21 Beckman Coulter, Inc. Nonseparation assay methods
AU2007249620A1 (en) 2006-05-09 2007-11-22 Musc Foundation For Research Development Detecting diastolic heart failure by protease and protease inhibitor plasma profiling
US7732153B2 (en) 2006-05-09 2010-06-08 Beckman Coulter, Inc. Nonseparation assay methods
US7642338B2 (en) * 2006-06-20 2010-01-05 Siemens Healthcare Diagnostics Inc. Tacrolimus standard and methods of using same
JP5385135B2 (en) 2006-07-03 2014-01-08 チャールズ デイビッド アデア， Composition for regulating expression of cell adhesion molecules
US20080026394A1 (en) * 2006-07-11 2008-01-31 Antara Biosciences Inc. Methods of detecting one or more cancer markers
JP2009544013A (en) * 2006-07-11 2009-12-10 エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント Prediction of heart failure after myocardial infarction by profiling proteases and protease inhibitors
MX2009000395A (en) 2006-07-14 2009-01-29 Chemocentryx Inc Triazolyl phenyl benzenesulfonamides.
WO2008021954A2 (en) * 2006-08-09 2008-02-21 Biogen Idec Ma Inc. Method for distribution of a drug
JP2008043332A (en) 2006-08-17 2008-02-28 Panomics Inc Quantitative determination of nucleic acid from tissue slide
EP2423333A1 (en) 2006-08-25 2012-02-29 Oncotherapy Science, Inc. Prognostic markers and therapeutic targets for lung cancer
US7951776B2 (en) 2006-09-01 2011-05-31 American Type Culture Collection Methods for treatment of type 1 diabetes
JP2008111824A (en) * 2006-09-01 2008-05-15 Nox Technologies Inc NEOPLASM SPECIFIC tNOX ISOFORM AND METHOD THEREFOR
US7985542B2 (en) 2006-09-07 2011-07-26 Institut Pasteur Genomic morse code
EP2469282A1 (en) 2006-09-08 2012-06-27 University of Oxford Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers
US8055034B2 (en) 2006-09-13 2011-11-08 Fluidigm Corporation Methods and systems for image processing of microfluidic devices
US8050516B2 (en) * 2006-09-13 2011-11-01 Fluidigm Corporation Methods and systems for determining a baseline during image processing
CA2665709C (en) * 2006-10-11 2018-04-03 Janssen Pharmaceutica N.V. Compositions and methods for treating and diagnosing irritable bowel syndrome
EP1912067A1 (en) * 2006-10-12 2008-04-16 Eppendorf Array Technologies S.A. Method for quantification of a target compound obtained from a biological sample upon chips
EP2426199A3 (en) 2006-10-20 2012-08-22 Danisco US Inc. Polyol oxidases
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
EP2097750A2 (en) * 2006-10-26 2009-09-09 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
EP2402752A3 (en) 2006-10-27 2012-06-06 Janssen Pharmaceutica, N.V. A method for pharmacologically profiling compounds
CA2668235A1 (en) 2006-11-02 2008-06-05 Yale University Assessment of oocyte competence
US8293684B2 (en) * 2006-11-29 2012-10-23 Exiqon Locked nucleic acid reagents for labelling nucleic acids
CA2671264C (en) 2006-11-30 2015-11-24 Research Development Foundation Improved immunoglobulin libraries
US8473216B2 (en) * 2006-11-30 2013-06-25 Fluidigm Corporation Method and program for performing baseline correction of amplification curves in a PCR experiment
US8232372B2 (en) 2006-12-14 2012-07-31 Schering Corp. Engineered anti-TSLP antibody
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
WO2008085895A2 (en) * 2007-01-04 2008-07-17 Musc Foundation For Research Development Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling
AU2008204338B2 (en) * 2007-01-11 2014-03-06 Erasmus University Medical Center Circular chromosome conformation capture (4C)
EP3103451A1 (en) 2007-01-12 2016-12-14 University of Maryland, Baltimore Targetting ncca-atp channel for organ protection following ischemic episode
DK2405007T5 (en) 2007-01-25 2014-06-23 Dupont Nutrition Biosci Aps Preparation of a Lipid Acyltransferase from Transformed Bacillus Licheniformis Cells
US20100055724A1 (en) 2007-01-26 2010-03-04 University Of Louisville Research Foundation, Inc. Methods of detecting autoantibodies for diagnosing and characterizing disorders
US8143046B2 (en) * 2007-02-07 2012-03-27 Danisco Us Inc., Genencor Division Variant Buttiauxella sp. phytases having altered properties
US20080220498A1 (en) * 2007-03-06 2008-09-11 Cervin Marguerite A Variant Buttiauxella sp. phytases having altered properties
US8828665B2 (en) 2007-02-16 2014-09-09 Ark Diagnostics, Inc. Compounds and methods for use in detecting gabapentin
KR100855299B1 (en) * 2007-02-16 2008-08-29 건국대학교 산학협력단 Monoclonal antibodies specific against il-32 antigens, hybridoma producing the monoclonal antibodies and diagnostic systems using the monoclonal antibodies
HUE042172T2 (en) 2007-02-23 2019-06-28 Merck Sharp & Dohme Engineered anti-il-23p19 antibodies
CN103396489A (en) 2007-02-23 2013-11-20 默沙东公司 Engineered anti-IL-23p19 antibodies
CN101675076B (en) 2007-02-28 2013-09-18 默沙东公司 Engineered anti-il-23r antibodies
EP2136843A1 (en) 2007-03-12 2009-12-30 Miraculins Inc. Biomarkers of prostate cancer and uses thereof
PL2145002T3 (en) 2007-03-30 2015-06-30 Engeneic Molecular Delivery Pty Ltd Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
CN105349685B (en) 2007-04-06 2020-08-04 贝克顿·迪金森公司 Compositions and methods for identifying carbapenemase genes
ES2529790T3 (en) 2007-04-13 2015-02-25 Dana-Farber Cancer Institute, Inc. Methods of treating cancer resistant to therapeutic agents of ERBB
US20100255004A1 (en) * 2007-04-13 2010-10-07 Dana Farber Cancer Institute Receptor tyrosine kinase profiling
US8003314B2 (en) 2007-04-16 2011-08-23 Diagnostic Hybrids, Inc. Methods for direct fluorescent antibody virus detection in liquids
EP2155789B1 (en) 2007-05-01 2013-07-24 Research Development Foundation Immunoglobulin fc libraries
US8795682B2 (en) * 2007-05-02 2014-08-05 Emory University Virus-like particles comprising chimeric human immunodeficiency virus (HIV)/mouse mammary tumor virus (MMTV) envelopes
US7776877B2 (en) * 2007-06-22 2010-08-17 Chemocentryx, Inc. N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
WO2009000089A1 (en) * 2007-06-28 2008-12-31 University Of Saskatchewan Immunomodulatory compositions and methods for treating disease with modified host defense peptides
CA2692761C (en) 2007-07-12 2013-04-30 Chemocentryx, Inc. Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation
WO2009014726A1 (en) 2007-07-26 2009-01-29 The Regents Of The University Of California Methods for enhancing bacterial cell display of proteins and peptides
AU2008284015B2 (en) 2007-08-03 2014-05-15 Musc Foundation For Research Development Human monoclonal antibodies and methods for producing the same
AU2008283902B2 (en) 2007-08-06 2014-03-13 Orion Genomics Llc Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the IGF2 gene
US7790401B2 (en) 2007-08-06 2010-09-07 Siemens Healthcare Diagnostics Methods for detection of immunosuppressant drugs
CN102264755A (en) 2007-08-08 2011-11-30 得克萨斯大学体系董事会 Vegfr-1/nrp-1 targeting peptides
WO2009023676A1 (en) * 2007-08-12 2009-02-19 Integrated Dna Technologies, Inc. Microarray system with improved sequence specificity
US20090136916A1 (en) * 2007-08-13 2009-05-28 Trustees Of Tufts College Methods and microarrays for detecting enteric viruses
EP2511708B1 (en) 2007-10-05 2016-09-14 Affymetrix, Inc. Highly multiplexed particle-based assays
AU2008312575B2 (en) * 2007-10-15 2012-02-23 Idexx Laboratories, Inc. Feline pancreatic lipase
WO2009062027A1 (en) * 2007-11-07 2009-05-14 Beckman Coulter, Inc. Nonseparation assay methods using peroxide generating enzymes
US7910378B2 (en) 2007-12-14 2011-03-22 Siemens Healthcare Diagnostics Inc. Methods for detection of hydrophobic drugs
JP5677703B2 (en) 2008-01-10 2015-02-25 リサーチ ディベロップメント ファウンデーション Vaccine and diagnosis for Ehrlichia chaffiensis
CN104107417B (en) 2008-02-07 2017-04-12 康奈尔大学 Methods For Preventing Or Treating Insulin Resistance
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
US20090311695A1 (en) * 2008-03-12 2009-12-17 Talat Nasim Method
WO2010115261A1 (en) 2009-03-27 2010-10-14 Genesis Genomics Inc. Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor
CA2719718C (en) 2008-03-28 2019-07-02 Mitomics, Inc. Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor
EP2107125A1 (en) 2008-03-31 2009-10-07 Eppendorf Array Technologies SA (EAT) Real-time PCR of targets on a micro-array
GB0807161D0 (en) * 2008-04-18 2008-05-21 Danisco Process
JP2011519034A (en) * 2008-04-23 2011-06-30 ルミネックス コーポレーション How to create standards for multiple specimens found in starting materials of biological origin
WO2009132124A2 (en) 2008-04-24 2009-10-29 The Trustees Of Columbia University In The City Of New York Geometric patterns and lipid bilayers for dna molecule organization and uses thereof
CN102083996A (en) 2008-04-30 2011-06-01 丹尼斯科公司 Oxidation process
AU2008356840B2 (en) * 2008-05-22 2013-05-16 Centre National De La Recherche Scientifique (Cnrs) New optically pure compounds for improved therapeutic efficiency
MX343490B (en) 2008-07-16 2016-11-08 Inst For Res In Biomedicine Human cytomegalovirus neutralizing antibodies and use thereof.
MX2011000542A (en) 2008-07-16 2011-08-03 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof.
US8871207B2 (en) 2008-07-25 2014-10-28 Humabs, LLC Neutralizing anti-influenza A virus antibodies and uses thereof
WO2010010467A2 (en) * 2008-07-25 2010-01-28 Institute For Research In Biomedicine Neutralizing anti-influenza a virus antibodies and uses thereof
WO2010036323A1 (en) 2008-09-25 2010-04-01 University Of Massachusetts Medical School Method of identifing interactions between genomic loci
WO2010048423A1 (en) 2008-10-24 2010-04-29 Ark Diagnostics, Inc. Levetiracetam immunoassays
JP5805538B2 (en) 2008-11-07 2015-11-04 リサーチ ディベロップメント ファウンデーション Compositions and methods for inhibiting Cripto / GSP78 complex formation and signaling
WO2010065437A1 (en) 2008-12-03 2010-06-10 Research Development Foundation Modulation of olfml-3 mediated angiogenesis
NZ593173A (en) 2008-12-05 2012-12-21 Abraxis Bioscience Llc Osteonectin (Secreted Protein, Acidic, Rich in Cysteines (SPARC)) binding ScFvS
WO2010066252A1 (en) 2008-12-09 2010-06-17 Dako Denmark A/S Method for evaluating pre-treatment
WO2010068757A1 (en) 2008-12-12 2010-06-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compositions and methods useful for detecting and treating diseases associated with 16p chromosomal disruptions
EP2955234A1 (en) 2009-02-11 2015-12-16 Orion Genomics, LLC Combinations of polymorphisms for determining allele-specific expression of igf2
PT3301446T (en) 2009-02-11 2020-07-14 Caris Mpi Inc Molecular profiling of tumors
WO2010096658A1 (en) 2009-02-19 2010-08-26 The Cleveland Clinic Foundation Corin as a marker for heart failure
US9347947B2 (en) * 2009-03-12 2016-05-24 Siemens Healthcare Diagnostics Inc. Immunoassays employing non-particulate chemiluminescent reagent
US20100240065A1 (en) * 2009-03-18 2010-09-23 Boehringer Ingelheim International Gmbh Prolyl Hydroxylase Compositions and Methods of Use Thereof
US8481698B2 (en) * 2009-03-19 2013-07-09 The President And Fellows Of Harvard College Parallel proximity ligation event analysis
TW201039841A (en) * 2009-03-27 2010-11-16 Gojo Ind Inc Compositions and methods for screening and using compounds antagonizing spore-surface interactions
SG175282A1 (en) 2009-04-21 2011-11-28 Genetic Technologies Ltd Methods for obtaining fetal genetic material
GB0908770D0 (en) 2009-04-24 2009-07-01 Danisco Method
CA2760569C (en) 2009-05-01 2018-01-02 Dako Denmark A/S New antibody cocktail
JP5813630B2 (en) 2009-05-14 2015-11-17 ザ チャンセラー，マスターズ アンド スカラーズ オブ ザ ユニバーシティ オブ オックスフォード Clinical diagnosis of liver fibrosis using a novel panel of trace human plasma protein biomarkers
MX2011012313A (en) 2009-05-19 2011-12-12 Danisco Use.
WO2011019423A2 (en) 2009-05-20 2011-02-17 Schering Corporation Modulation of pilr receptors to treat microbial infections
KR20120122869A (en) 2009-06-02 2012-11-07 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
KR20120103431A (en) 2009-06-25 2012-09-19 대니스코 에이/에스 Protein
US20110165595A1 (en) * 2009-07-13 2011-07-07 Catanzaro Brian E Apparatus and methods for processing a whole blood sample
DK3406717T3 (en) 2009-07-17 2020-03-16 Bioatla Llc AT THE SAME TIME, INTEGRATED SELECTION AND DEVELOPMENT OF ANTIBODY / PROTEIN PERFORMANCE AND EXPRESSION OF PRODUCT HOUSES
PL3023438T3 (en) 2009-09-03 2020-07-27 Merck Sharp & Dohme Corp. Anti-gitr antibodies
US20130023433A1 (en) 2009-09-28 2013-01-24 Yuling Luo Methods of detecting nucleic acid sequences with high specificity
CA2777053A1 (en) 2009-10-06 2011-04-14 The Board Of Trustees Of The University Of Illinois Human single-chain t cell receptors
JP2013507618A (en) 2009-10-11 2013-03-04 バイオジェン・アイデック・エムエイ・インコーポレイテッド Anti-VLA-4 related assays
EP2494077A4 (en) 2009-10-27 2013-08-21 Caris Mpi Inc Molecular profiling for personalized medicine
WO2011062997A2 (en) 2009-11-17 2011-05-26 Musc Foundation For Research Development Human monoclonal antibodies to human nucleolin
GB0920089D0 (en) 2009-11-17 2009-12-30 Danisco Method
US8592151B2 (en) * 2009-11-17 2013-11-26 Musc Foundation For Research Development Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids
US20130183326A9 (en) 2009-11-20 2013-07-18 St. Jude Children's Research Hospital Methods and compositions for modulating the activity of the interleukin-35 receptor complex
US9733242B2 (en) 2012-10-07 2017-08-15 Sevident, Inc. Devices for capturing analyte
US9910040B2 (en) 2012-07-09 2018-03-06 Sevident, Inc. Molecular nets comprising capture agents and linking agents
US8835120B2 (en) 2009-12-02 2014-09-16 Abbott Laboratories Assay for cardiac troponin-T (cTnT)
US8652788B2 (en) * 2009-12-02 2014-02-18 Abbott Laboratories Assay for diagnosis of cardiac myocyte damage
US8183002B2 (en) * 2009-12-03 2012-05-22 Abbott Laboratories Autoantibody enhanced immunoassays and kits
US20110136141A1 (en) 2009-12-03 2011-06-09 Abbott Laboratories Peptide reagents and method for inhibiting autoantibody antigen binding
EP2513308B1 (en) 2009-12-17 2017-01-18 Merck Sharp & Dohme Corp. Modulation of pilr to treat immune disorders
GB0922377D0 (en) 2009-12-22 2010-02-03 Arab Gulf University The Mutant LDL receptor
AU2011203815B2 (en) 2010-01-11 2015-11-26 Biogen Ma Inc. Assay for JC virus antibodies
US11287423B2 (en) 2010-01-11 2022-03-29 Biogen Ma Inc. Assay for JC virus antibodies
CA2787311C (en) 2010-01-27 2017-08-15 Yeda Research And Development Co. Ltd. Antibodies that inhibit metalloproteins
EP2529030B1 (en) 2010-01-29 2019-03-13 Advanced Cell Diagnostics, Inc. Methods of in situ detection of nucleic acids
US8574832B2 (en) * 2010-02-03 2013-11-05 Massachusetts Institute Of Technology Methods for preparing sequencing libraries
MX2012008884A (en) 2010-02-08 2012-08-31 Agensys Inc Antibody drug conjugates (adc) that bind to 161p2f10b proteins.
WO2011114251A1 (en) 2010-03-18 2011-09-22 Danisco A/S Foodstuff
CA2795554C (en) 2010-04-06 2021-07-13 Massachusetts Institute Of Technology Gene-expression profiling with reduced numbers of transcript measurements
US9125931B2 (en) 2010-04-06 2015-09-08 Massachusetts Institute Of Technology Post-transcriptional regulation of RNA-related processes using encoded protein-binding RNA aptamers
WO2011129382A1 (en) 2010-04-16 2011-10-20 Abbott Japan Co. Ltd. Methods and reagents for diagnosing rheumatoid arthritis
WO2011140234A1 (en) 2010-05-07 2011-11-10 Abbott Laboratories Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
US20120190563A1 (en) 2010-05-07 2012-07-26 Abbott Laboratories Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
WO2011146479A1 (en) 2010-05-18 2011-11-24 The Texas A&M University System Method and composition for the diagnosis and monitoring of inflammatory diseases
US8329424B2 (en) 2010-06-25 2012-12-11 Siemens Healthcare Diagnostics Reduction in false results in assay measurements
US20130316338A1 (en) 2010-06-29 2013-11-28 The United States Government As Represented By The Department Of Veterans Affairs CCR6 As A Biomarker of Alzheimer's Disease
GB201011513D0 (en) 2010-07-08 2010-08-25 Danisco Method
EP2407242A1 (en) 2010-07-13 2012-01-18 Dublin City University Direct clone analysis and selection technology
WO2012009026A2 (en) 2010-07-16 2012-01-19 Bioatla Llc Novel methods of protein evolution
WO2012009627A2 (en) 2010-07-16 2012-01-19 Vanderbilt University Low resource processor using surface tension valves for extracting, concentrating and detecting molecular species
US20120021944A1 (en) 2010-07-23 2012-01-26 Harold Baker Co-Coupling To Control Reactivity Of Reagents In Immunoassays
US9120862B2 (en) 2010-07-26 2015-09-01 Abbott Laboratories Antibodies relating to PIVKA-II and uses thereof
EP2601531A1 (en) 2010-08-04 2013-06-12 IDEXX Laboratories, Inc. Detection of degradation products of canine nt-probnp
US10088490B2 (en) 2010-08-20 2018-10-02 Siemens Healthcare Diagnostics Inc. Assay for analytes using multiple receptors
EP2619321B1 (en) 2010-09-20 2018-08-01 Advanced Cell Diagnostics, Inc. Biomarkers for differentiating melanoma from benign nevus in the skin
ES2874306T3 (en) 2010-09-29 2021-11-04 Agensys Inc Conjugates of antibodies and drugs (CAF) that bind to 191P4D12 proteins
CA2813665A1 (en) 2010-10-04 2012-04-12 Elro Pharma Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans
EP2441520A1 (en) 2010-10-12 2012-04-18 Eppendorf AG Real-time amplification and micro-array based detection of nucleic acid targets in a flow chip assay
EP3034625B1 (en) 2010-10-21 2017-10-04 Advanced Cell Diagnostics, Inc. An ultra sensitive method for in situ detection of nucleic acids
WO2012075111A1 (en) 2010-11-30 2012-06-07 Novartis Ag Uses of anti-cd40 antibodies in combination therapy for b cell-related cancers
AR084358A1 (en) 2010-12-27 2013-05-08 Lilly Co Eli COMPOSITIONS AND METHODS FOR IDENTIFYING AND DIFFERING VIRAL COMPONENTS OF MULTIVALENT VACCINES OF THE “BOILING FEVER” (BOVINE RESPIRATORY DISEASE COMPLEX (BRDC))
AU2011352207B2 (en) 2010-12-31 2016-03-03 Bioatla, Llc Comprehensive monoclonal antibody generation
DK3216878T3 (en) 2011-01-17 2019-06-11 Life Technologies Corp WORKING PROCEDURE FOR DETERMINING LIGANDS BY USING NUCLEAR ACIDS
EP2668290B1 (en) 2011-01-28 2017-05-31 Advanced Cell Diagnostics, Inc. Rnascope® hpv assay for determining hpv status in head and neck cancers and cervical lesions
US8952132B2 (en) 2011-02-07 2015-02-10 Research Development Foundation Engineered immunoglobulin FC polypeptides
EP2678042B1 (en) 2011-02-23 2018-05-09 The Board of Trustees of the University of Illionis Amphiphilic dendron-coils, micelles thereof and uses
CA2829300A1 (en) 2011-03-08 2012-09-13 King Abdullah University Of Science And Technology Molecular biomarker set for early detection of ovarian cancer
EP2684048B1 (en) 2011-03-11 2018-10-03 Board of Regents of the University of Nebraska Biomarker for coronary artery disease
WO2012131594A1 (en) 2011-03-28 2012-10-04 Novartis Ag Markers associated with cyclin-dependent kinase inhibitors
KR20230013283A (en) 2011-04-01 2023-01-26 이뮤노젠 아이엔씨 Methods for increasing efficacy of folr1 cancer therapy
EP2694095B1 (en) 2011-04-05 2018-03-07 Longevity Biotech, Inc. Compositions comprising glucagon analogs and methods of making and using the same
BR112013025811A2 (en) 2011-04-08 2016-11-29 Danisco Us Inc "composition and method for removing a lipid based stain from a surface"
US9150644B2 (en) 2011-04-12 2015-10-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
JP2014515476A (en) 2011-05-20 2014-06-30 アボットジャパン株式会社 Immunoassay methods and reagents for reducing non-specific binding
WO2012162179A1 (en) 2011-05-20 2012-11-29 Oligomerix, Inc. Tau protease compositions and methods of use
EP2715353B1 (en) 2011-05-31 2016-08-24 IDEXX Laboratories, Inc. DETECTION OF DEGRADATION PRODUCTS OF FELINE NT-proBNP
SI2715352T1 (en) 2011-05-31 2019-06-28 Biogen Ma Inc. Method of assessing risk of pml
US9835621B2 (en) 2011-07-14 2017-12-05 University Of Kentucky Research Foundation Process for detection of alzheimer's disease from a serum sample
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
PL3418300T3 (en) 2011-07-18 2021-05-04 Institute For Research In Biomedicine Neutralizing anti-influenza a virus antibodies and uses thereof
JP2014523914A (en) 2011-07-18 2014-09-18 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Engineered microbial targeting molecules and uses thereof
AU2012294814A1 (en) 2011-08-05 2014-02-27 Research Development Foundation Improved methods and compositions for modulation of Olfml3 mediated angiogenesis
EP2742352B1 (en) 2011-08-12 2018-02-28 Siemens Healthcare Diagnostics Inc. Detection of sex steroids
CN103906535B (en) 2011-08-15 2017-07-14 芝加哥大学 The composition related to the antibody of staphylococcal protein A and method
EP2744828A4 (en) 2011-08-16 2014-12-31 Univ Emory Jaml specific binding agents, antibodies, and uses related thereto
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
JP6844939B2 (en) 2011-10-21 2021-03-17 オ−グレックス ライフ サイエンシズ コーポレイション Citrullinated 14-3-3 derived antigen and its use in the diagnosis of rheumatoid arthritis
CN102507917A (en) * 2011-11-01 2012-06-20 四川金域医学检验中心有限公司 Valproic acid homogeneous-phase enzyme immunity rapid detection kit
WO2013101758A1 (en) 2011-12-29 2013-07-04 Baylor Research Institute Biomarkers for kawasaki disease
US10139405B2 (en) 2012-01-24 2018-11-27 Cd Diagnostics, Inc. System for detecting infection in synovial fluid
US8771964B2 (en) 2012-02-02 2014-07-08 Siemens Healthcare Diagnostics Inc. Compositions and methods for detection of methadone metabolite
ES2645617T3 (en) 2012-02-29 2017-12-07 Chemocentryx, Inc. Pyrazol-1-yl benzene sulfonamides as CCR9 antagonists
US8586322B2 (en) 2012-03-07 2013-11-19 Siemens Healthcare Diagnostics, Inc Sandwich assay for immunosuppressant drugs
CA2867902C (en) 2012-03-20 2023-09-26 Biogen Idec Ma Inc. Jcv neutralizing antibodies
BR112014023063A2 (en) 2012-03-20 2017-07-18 Corti Davide antibodies that neutralize rsv, mpv and pvm and their uses
US9283272B2 (en) 2012-03-30 2016-03-15 The United States Of America As Represented By The Department Of Veterans Affairs Targeting intracellular target-binding determinants with intracellular antibodies
US20140178869A1 (en) 2012-04-05 2014-06-26 Advanced Cell Diagnostics, Inc. Detection of immunoglobulin light chain restriction by rna in situ hybridization
US20130280696A1 (en) 2012-04-23 2013-10-24 Elliott Millenson Devices and methods for detecting analyte in bodily fluid
CA2910320A1 (en) 2012-04-26 2013-10-31 University Of Chicago Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
US9658218B2 (en) 2012-05-07 2017-05-23 Siemens Healthcare Diagnostics Inc. Determination of total analyte concentration
CN104583239B (en) 2012-05-10 2018-09-18 生物蛋白有限公司 More specific monoclonal antibodies
MX369626B (en) 2012-05-24 2019-11-13 Mountgate Group Ltd Compositions and methods related to prevention and treatment of rabies infection.
EP3679923B1 (en) 2012-06-01 2021-08-04 Icahn School of Medicine at Mount Sinai Ceramide levels in the treatment and prevention of infections
JP6366580B2 (en) 2012-06-22 2018-08-01 エイチティージー モレキュラー ダイアグノスティクス， インコーポレイテッド Molecular malignancy in melanocytic lesions
WO2014004444A1 (en) 2012-06-27 2014-01-03 Siemens Healthcare Diagnostics Inc. Compositions and methods for liquid mixing assessment
EP3309263B1 (en) 2012-07-09 2019-12-25 Novartis AG Biomarkers associated with cdk inhibitors
EP2875078B1 (en) 2012-07-18 2017-12-20 President and Fellows of Harvard College Modification of surfaces for simulataneous repellency and targeted binding of desired moieties
WO2014018863A1 (en) 2012-07-27 2014-01-30 The Board Of Trustees Of The University Of Illinois Engineering t-cell receptors
US9371568B2 (en) 2012-07-31 2016-06-21 Novartis Ag Markers associated with human double minute 2 inhibitors
PL2887959T3 (en) 2012-08-23 2019-04-30 Agensys Inc Antibody drug conjugates (adc) that bind to 158p1d7 proteins
EP4356927A2 (en) 2012-10-12 2024-04-24 Arizona Board of Regents on behalf of Arizona State University Antibody based reagents that specifically recognize toxic oligomeric forms of tau
WO2014063097A1 (en) 2012-10-19 2014-04-24 Danisco Us Inc. Stabilization of biomimetic membranes
WO2014062635A1 (en) 2012-10-19 2014-04-24 Novartis Ag Markers for acute lymphoblastic leukemia
US9395369B2 (en) 2012-10-19 2016-07-19 Regents Of The University Of Minnesota Guinea pig cytomegalovirus (CIDMTR strain)
WO2014066590A1 (en) 2012-10-24 2014-05-01 Research Development Foundation Jam-c antibodies and methods for treatment of cancer
US9244083B2 (en) 2012-11-30 2016-01-26 Siemens Healthcare Diagnostics Inc. Compositions and methods for detecting vitamin D
US9121859B2 (en) 2012-12-04 2015-09-01 Siemens Healthcare Diagnostics Inc. Compounds and methods for determination of FKBP-binding immunosuppressant drugs
WO2014107373A1 (en) 2013-01-02 2014-07-10 N-Dia, Inc. Methods for predicting time-to-delivery in pregnant women
WO2014113717A1 (en) 2013-01-18 2014-07-24 Ark Diagnostics, Inc. Voriconazole immunoassays
WO2014116721A1 (en) 2013-01-22 2014-07-31 The Arizona Board Of Regents For And On Behalf Of Arizona State University Geminiviral vector for expression of rituximab
US9411930B2 (en) 2013-02-01 2016-08-09 The Regents Of The University Of California Methods for genome assembly and haplotype phasing
GB2519255B (en) 2013-02-01 2016-01-06 Univ California Methods for genome assembly and haplotype phasing
DK2951290T3 (en) 2013-02-01 2018-01-22 Us Health PROCEDURE FOR PREPARING RETINAL PIGMENTAL EPIT (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCS)
EP2956444B1 (en) 2013-02-13 2018-05-30 ARK Diagnostics, Inc. Posaconazole immunoassays
WO2014130846A1 (en) 2013-02-22 2014-08-28 Seungpyo Hong Transdermal drug delivery using amphiphilic dendron-coil micelles
TWI582239B (en) 2013-03-11 2017-05-11 諾華公司 Markers associated with wnt inhibitors
WO2014159242A1 (en) 2013-03-14 2014-10-02 Novartis Ag Notch 3 mutants and uses thereof
WO2014159239A2 (en) 2013-03-14 2014-10-02 Novartis Ag Antibodies against notch 3
US9273349B2 (en) 2013-03-14 2016-03-01 Affymetrix, Inc. Detection of nucleic acids
WO2014145718A2 (en) 2013-03-15 2014-09-18 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same
US9944992B2 (en) 2013-03-15 2018-04-17 The University Of Chicago Methods and compositions related to T-cell activity
MY193211A (en) 2013-03-15 2022-09-26 Bayer Healthcare Llc Gla domains as targeting agents
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
US20140308751A1 (en) 2013-04-12 2014-10-16 Siemens Healthcare Diagnostics Inc. Assays for Analyte Homologs
US20160091485A1 (en) 2013-04-25 2016-03-31 The Broad Institute, Inc. Markers for ezh2 inhibitors
US10203338B2 (en) 2013-05-14 2019-02-12 Siemens Healthcare Diagnostics Inc. Stabilized liquid formulations containing receptors
JP6649250B2 (en) 2013-05-21 2020-02-19 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Engineered heme binding constructs and uses thereof
US10119976B2 (en) 2013-05-28 2018-11-06 Biogen Ma Inc. Method of assessing risk of PML
JP6600302B2 (en) 2013-06-12 2019-10-30 ザ ジェネラル ホスピタル コーポレイション Methods, kits, and systems for multiplex detection of target molecules and uses thereof
RU2689553C2 (en) 2013-06-18 2019-05-28 Днатрикс, Инк. Cerebral cancer treatment with oncolytic adenovirus
AU2014302082B2 (en) 2013-06-28 2019-08-08 Baylor Research Institute Dendritic cell ASGPR targeting immunotherapeutics for multiple sclerosis
AU2014296219A1 (en) 2013-08-01 2016-02-25 Agensys, Inc. Antibody drug conjugates (ADC) that bind to CD37 proteins
CN106659909B (en) 2013-08-21 2022-01-11 德克萨斯州大学系统董事会 Compositions and methods for targeting connexin hemichannels
AU2014312086B2 (en) 2013-08-30 2020-03-12 Immunogen, Inc. Antibodies and assays for detection of folate receptor 1
CN105848722B (en) 2013-10-02 2021-09-03 免疫医疗有限责任公司 Neutralizing anti-influenza a antibodies and uses thereof
SG11201602540XA (en) 2013-10-03 2016-04-28 Oklahoma Med Res Found Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
US9476884B2 (en) 2013-10-04 2016-10-25 University Of Massachusetts Hybridization- independent labeling of repetitive DNA sequence in human chromosomes
US20160252507A1 (en) 2013-10-24 2016-09-01 Siemens Healthcare Diagnostics Inc. Assays for macromolecular analytes
US20170002064A1 (en) 2013-11-08 2017-01-05 The Board Of Regents Of The University Of Texas System Vh4 antibodies against gray matter neuron and astrocyte
US10172916B2 (en) 2013-11-15 2019-01-08 The Board Of Trustees Of The Leland Stanford Junior University Methods of treating heart failure with agonists of hypocretin receptor 2
CA2931220A1 (en) 2013-11-20 2015-05-28 University Of Iowa Research Foundation Methods and compositions for treating amyloid deposits
WO2015077615A1 (en) 2013-11-22 2015-05-28 The Board Of Trustees Of The University Of Illinois Engineered high-affinity human t cell receptors
US20160313310A1 (en) 2013-12-13 2016-10-27 Siemens Healthcare Diagnostics Inc. Pretreatment agent in non-agglutination assays
WO2015095604A2 (en) 2013-12-18 2015-06-25 President And Fellows Of Harvard College Methods and assays relating to circulating tumor cells
ES2767964T3 (en) 2013-12-18 2020-06-19 Siemens Healthcare Diagnostics Inc Detection of endothelial disease
CA2934039A1 (en) 2013-12-19 2015-06-25 Danisco Us Inc. Use of hydrophobins to increase gas transferin aerobic fermentation processes
EP3447493B1 (en) 2014-01-07 2020-05-13 Bioatla, LLC Proteins targeting orthologs
AU2015204503B2 (en) 2014-01-13 2020-07-09 Baylor Research Institute Novel vaccines against HPV and HPV-related diseases
KR102448454B1 (en) 2014-01-29 2022-09-28 다나-파버 캔서 인스티튜트 인크. Antibodies against the muc1-c/extracellular domain (muc1-c/ecd)
US20150247204A1 (en) 2014-02-07 2015-09-03 The General Hopital Corporation Differential diagnosis of hepatic neoplasms
WO2015123565A1 (en) 2014-02-14 2015-08-20 The General Hospital Corporation Methods for diagnosing igg4-related disease
US20150247205A1 (en) 2014-02-28 2015-09-03 The General Hospital Corporation Diagnosis of multiple myeloma and lymphoma
US10247729B2 (en) 2014-05-05 2019-04-02 Microbplex, Inc. Media elaborated with newly synthesized antibodies (MENSA) and uses thereof
EP3140653B1 (en) 2014-05-08 2022-05-11 Novodiax, Inc. Direct immunohistochemistry assay
WO2015179435A1 (en) 2014-05-19 2015-11-26 Bayer Healthcare Llc Optimized humanized monoclonal antibodies against activated protein c and uses thereof
EP3161005B1 (en) 2014-06-27 2020-11-25 Siemens Healthcare Diagnostics Inc. Binding partners specific for vitamin d epimers in vitamin d assays
BR112016030560A8 (en) 2014-06-27 2021-07-13 Siemens Healthcare Diagnostics Inc specific binding partners for vitamin d epimers, antibody, and method for separating an epimeric vitamin d from a sample suspected of containing an epimeric vitamin d
US10294292B2 (en) 2014-07-15 2019-05-21 Medimmune, Llc Neutralizing anti-influenza B antibodies and uses thereof
US10526641B2 (en) 2014-08-01 2020-01-07 Dovetail Genomics, Llc Tagging nucleic acids for sequence assembly
US20180010132A1 (en) 2014-09-11 2018-01-11 Novartis Ag Inhibition of prmt5 to treat mtap-deficiency-related diseases
CA2944085C (en) 2014-09-16 2018-04-10 Ease Charm Limited Anti-egfr antibody and uses of same
IL292655B2 (en) 2014-10-06 2024-03-01 Chemocentryx Inc Ccr9 chemokine receptor inhibitor for use in a method of treating or reducing the development of inflammatory bowel disease
WO2016055950A1 (en) 2014-10-08 2016-04-14 Novartis Ag Combination of human cytomegalovirus neutralizing antibodies
US20170253921A1 (en) 2014-10-13 2017-09-07 Life Technologies Corporation Methods, kits & compositions for determining gene copy numbers
EP3739062B1 (en) 2014-10-20 2023-08-16 Gen-Probe Incorporated Red blood cell lysis solution
MX2017005268A (en) 2014-10-24 2017-07-26 Dupont Nutrition Biosci Aps Proline tolerant tripeptidyl peptidases and uses thereof.
EP3172329A1 (en) 2014-10-24 2017-05-31 Danisco US Inc. Method for producing alcohol by use of a tripeptidyl peptidase
WO2016075546A2 (en) 2014-11-14 2016-05-19 Antonio Lanzavecchia Antibodies that neutralize ebola virus and uses thereof
WO2016078761A1 (en) 2014-11-18 2016-05-26 Humabs Biomed Sa Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof
US10479997B2 (en) 2014-12-01 2019-11-19 Novartis Ag Compositions and methods for diagnosis and treatment of prostate cancer
EP3227462B1 (en) 2014-12-01 2020-04-22 The Broad Institute, Inc. Method for in situ determination of nucleic acid proximity
WO2016094425A1 (en) 2014-12-08 2016-06-16 Berg Llc Use of markers including filamin a in the diagnosis and treatment of prostate cancer
EP3234607B1 (en) 2014-12-17 2021-04-28 Siemens Healthcare Diagnostics Inc. Sandwich assay design for small molecules
KR20220151045A (en) 2014-12-23 2022-11-11 4디 파마 리서치 리미티드 Immune modulation
SG10202105996WA (en) 2014-12-23 2021-07-29 4D Pharma Res Ltd Pirin polypeptide and immune modulation
WO2016130516A1 (en) 2015-02-09 2016-08-18 Research Development Foundation Engineered immunoglobulin fc polypeptides displaying improved complement activation
SG10202000731WA (en) 2015-02-17 2020-03-30 Dovetail Genomics Llc Nucleic acid sequence assembly
US10479825B2 (en) 2015-02-25 2019-11-19 Vanderbilt University Antibody-mediated neutralization of Marburg virus
US9958464B2 (en) 2015-03-03 2018-05-01 Ark Diagnostics, Inc. Pregabalin immunoassays
MY178919A (en) 2015-03-09 2020-10-23 Agensys Inc Antibody drug conjugates (adc) that bind to flt3 proteins
US11873483B2 (en) 2015-03-11 2024-01-16 The Broad Institute, Inc. Proteomic analysis with nucleic acid identifiers
WO2016154540A1 (en) 2015-03-26 2016-09-29 Dovetail Genomics Llc Physical linkage preservation in dna storage
ES2904573T3 (en) 2015-03-27 2022-04-05 Univ Southern California LHR-directed T cell therapy for the treatment of solid tumors
US9612534B2 (en) 2015-03-31 2017-04-04 Tokyo Electron Limited Exposure dose homogenization through rotation, translation, and variable processing conditions
WO2016182984A1 (en) 2015-05-08 2016-11-17 Centrillion Technology Holdings Corporation Disulfide-linked reversible terminators
HUE056407T2 (en) 2015-06-01 2022-02-28 Medimmune Llc Neutralizing anti-influenza binding molecules and uses thereof
CA2987992A1 (en) 2015-06-04 2016-12-08 University Of Southern California Lym-1 and lym-2 targeted car cell immunotherapy
MD3240554T2 (en) 2015-06-15 2020-01-31 4D Pharma Res Ltd Blautia stercosis and wexlerae for use in treating inflammatory and autoimmune diseases
MA41060B1 (en) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41010B1 (en) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprising bacterial strains
RS59308B1 (en) 2015-06-15 2019-10-31 4D Pharma Res Ltd Compositions comprising bacterial strains
PL3206700T3 (en) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2016207402A1 (en) 2015-06-26 2016-12-29 Institute For Research In Biomedicine Proteins comprising a mutated lair-1 fragment and uses thereof
WO2016210395A1 (en) 2015-06-26 2016-12-29 Dupont Nutrition Biosciences Aps Aminopeptidases for protein hydrlyzates
CN108291330A (en) 2015-07-10 2018-07-17 西弗吉尼亚大学 The marker of palsy and palsy seriousness
WO2017015334A1 (en) 2015-07-21 2017-01-26 Saint Louis University Compositions and methods for diagnosing and treating endometriosis-related infertility
WO2017023929A1 (en) 2015-08-04 2017-02-09 Cd Diagnostics, Inc. Methods for detecting adverse local tissue reaction (altr) necrosis
EP3331549B1 (en) 2015-08-06 2020-12-23 President and Fellows of Harvard College Improved microbe-binding molecules and uses thereof
EP3337908A4 (en) 2015-08-18 2019-01-23 The Broad Institute, Inc. Methods and compositions for altering function and structure of chromatin loops and/or domains
WO2017033152A1 (en) 2015-08-25 2017-03-02 Prothena Biosciences Limited Methods for detecting phosphorylated alpha-synuclein
WO2017040380A2 (en) 2015-08-28 2017-03-09 Research Development Foundation Engineered antibody fc variants
WO2017040813A2 (en) 2015-09-02 2017-03-09 University Of Massachusetts Detection of gene loci with crispr arrayed repeats and/or polychromatic single guide ribonucleic acids
CA3036409C (en) 2015-09-08 2023-07-11 Erik J. Sontheimer Dnase h activity of neisseria meningitidis cas9
EP3353547A1 (en) 2015-09-22 2018-08-01 Delta TM Technologies Designing customized protein-specific buffer systems
JP6836586B2 (en) 2015-09-29 2021-03-03 エイチティージー モレキュラー ダイアグノスティクス， インコーポレイテッド Methods for Subtyping Diffuse Large B-Cell Lymphoma (DLBCL)
WO2017059878A1 (en) 2015-10-07 2017-04-13 Humabs Biomed Sa Antibodies that potently neutralize hepatitis b virus and uses thereof
AU2016334401A1 (en) 2015-10-10 2018-04-26 Intrexon Corporation Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
WO2017066211A1 (en) 2015-10-12 2017-04-20 Advanced Cell Diagnostics, Inc. In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto
AU2016341198B2 (en) 2015-10-19 2023-03-09 Dovetail Genomics, Llc Methods for genome assembly, haplotype phasing, and target independent nucleic acid detection
ES2863624T3 (en) 2015-10-29 2021-10-11 Siemens Healthcare Diagnostics Inc Small molecule sandwich assay
CA3004438A1 (en) 2015-11-09 2017-05-18 The Children's Hospital Of Philadelphia Glypican 2 as a cancer marker and therapeutic target
ME03003B (en) 2015-11-20 2018-10-20 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2017096051A1 (en) 2015-12-02 2017-06-08 Stcube & Co., Inc. Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof
CN108925136B (en) 2015-12-02 2022-02-01 斯特赛恩斯公司 Antibodies specific for glycosylated BTLA (B and T lymphocyte attenuating factor)
EP3383418B1 (en) 2015-12-04 2021-10-20 Board of Regents, The University of Texas System Slc45a2 peptides for immunotherapy
JOP20200228A1 (en) 2015-12-21 2017-06-16 Novartis Ag Compositions and methods for decreasing tau expression
WO2017112492A2 (en) 2015-12-22 2017-06-29 The Regents Of The University Of Colorado, A Body Corporate Protecting rnas from degradation using engineered viral rnas
EP3402513A4 (en) 2016-01-13 2019-10-23 Medlmmune, LLC Method of treating influenza a
US10337050B2 (en) 2016-02-11 2019-07-02 Qiagen Sciences, Llc Polyphenolic additives in sequencing by synthesis
US10036011B2 (en) 2016-02-11 2018-07-31 Qiagen Waltham, Inc. Scavenger compounds for improved sequencing-by-synthesis
WO2017147186A1 (en) 2016-02-22 2017-08-31 Ursure, Inc. System and method for detecting therapeutic agents to monitor adherence to a treatment regimen
SG11201807117WA (en) 2016-02-23 2018-09-27 Dovetail Genomics Llc Generation of phased read-sets for genome assembly and haplotype phasing
EP3420097A1 (en) 2016-02-25 2019-01-02 DuPont Nutrition Biosciences ApS Method for producing a protein hydrolysate employing an aspergillus fumigatus tripeptidyl peptidase
EP3419998A4 (en) 2016-02-26 2019-09-25 The Board of Regents of The University of Texas System CONNEXIN (Cx) 43 HEMICHANNEL-BINDING ANTIBODIES AND USES THEREOF
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
RS58869B1 (en) 2016-03-04 2019-08-30 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
US10960013B2 (en) 2016-03-04 2021-03-30 East Carolina University J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders
WO2017165438A1 (en) 2016-03-25 2017-09-28 Muralidhar Reddy Moola Combinatorial synthesis and biomarker development
WO2017172518A1 (en) 2016-03-29 2017-10-05 Stcube, Inc. Dual function antibodies specific to glycosylated pd-l1 and methods of use thereof
US11046782B2 (en) 2016-03-30 2021-06-29 Musc Foundation For Research Development Methods for treatment and diagnosis of cancer by targeting glycoprotein A repetitions predominant (GARP) and for providing effective immunotherapy alone or in combination
EP3448998B1 (en) 2016-04-27 2020-06-03 Gen-Probe Incorporated Blood cell lysis reagent
WO2017194589A1 (en) 2016-05-10 2017-11-16 Vib Vzw Inhibition of tau-mediated early synaptic dysfunction
SG11201810088SA (en) 2016-05-13 2018-12-28 Dovetail Genomics Llc Recovering long-range linkage information from preserved samples
AU2017268248A1 (en) 2016-05-16 2018-12-13 President And Fellows Of Harvard College Aqueous biomolecule coupling on CO2-plasma-activated surfaces
AU2017278261A1 (en) 2016-06-05 2019-01-31 Berg Llc Systems and methods for patient stratification and identification of potential biomarkers
WO2018010789A1 (en) 2016-07-13 2018-01-18 Humabs Biomed Sa Novel antibodies specifically binding to zika virus epitopes and uses thereof
TW201821093A (en) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 Compositions comprising bacterial strains
JP2019528251A (en) 2016-07-20 2019-10-10 エスティーキューブ，インコーポレイテッド Methods of treating and treating cancer using a combination of antibodies that bind to glycosylated PD-L1
WO2018015296A1 (en) 2016-07-20 2018-01-25 Vib Vzw Therapeutic agents for neurological and psychiatric disorders
WO2018035281A1 (en) 2016-08-17 2018-02-22 North Carolina State University Northern-southern route to synthesis of bacteriochlorins
US20180128828A1 (en) 2016-11-04 2018-05-10 James W. Stave Direct detection of microorganisms in patient samples by immunoassay
EP3538093B1 (en) 2016-11-09 2023-10-25 Qiagen Sciences, LLC Photoprotective mixtures as imaging reagents in sequencing-by-synthesis
RU2765737C2 (en) 2016-11-23 2022-02-02 Хемоцентрикс, Инк. Method for treating focal segmental glomerulosclerosis
CN110199031A (en) 2016-11-29 2019-09-03 基因组影像公司 Method designed for analyzing one group of polynucleotide sequence of the particular event in interested genetic region
WO2018102252A1 (en) 2016-11-30 2018-06-07 North Carolina State University Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
US10935555B2 (en) 2016-12-22 2021-03-02 Qiagen Sciences, Llc Determining candidate for induction of labor
US10656164B2 (en) 2016-12-22 2020-05-19 Qiagen Sciences, Llc Screening asymptomatic pregnant woman for preterm birth
AU2018213315A1 (en) 2017-01-26 2019-07-25 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
EP3574009A4 (en) 2017-01-26 2020-11-25 Zlip Holding Limited Cd47 antigen binding unit and uses thereof
EP3576758A4 (en) 2017-01-31 2020-12-09 Vanderbilt University Generation of human allergen-and helminth-specific ige monoclonal antibodies for diagnostic and therapeutic use
US11179413B2 (en) 2017-03-06 2021-11-23 Novartis Ag Methods of treatment of cancer with reduced UBB expression
EA201992434A1 (en) 2017-04-19 2020-03-30 Инститьют Фор Рисерч Ин Байомедисин NEW ANTI-MALARIA VACCINES AND ANTIBODIES RELATING TO PLASMODIA SPOROZOITES
TWI787272B (en) 2017-05-22 2022-12-21 英商4D製藥研究有限公司 Compositions comprising bacterial strains
JP6978514B2 (en) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited Composition containing bacterial strain
KR20200015602A (en) 2017-05-31 2020-02-12 주식회사 에스티큐브앤컴퍼니 Antibodies and molecules immunospecifically binding to BTN1A1 and therapeutic uses thereof
US20200131266A1 (en) 2017-05-31 2020-04-30 Stcube & Co., Inc. Methods of treating cancer using antibodies and molecules that immunospecifically bind to btn1a1
CN110997724A (en) 2017-06-06 2020-04-10 斯特库伯株式会社 Methods of treating cancer using antibodies and molecules that bind BTN1A1 or BTN1A 1-ligands
JP6884889B2 (en) 2017-06-14 2021-06-09 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ Compositions Containing Bacterial Strains
KR20200015575A (en) 2017-06-14 2020-02-12 4디 파마 리서치 리미티드 Compositions Containing Bacterial Strains
US10768185B2 (en) 2017-07-20 2020-09-08 Trustees Of Boston University Tenofovir detection assay
US11530413B2 (en) 2017-07-21 2022-12-20 Novartis Ag Compositions and methods to treat cancer
SG11202000387YA (en) 2017-08-25 2020-03-30 Five Prime Therapeutics Inc B7-h4 antibodies and methods of use thereof
WO2019042555A1 (en) 2017-08-31 2019-03-07 Humabs Biomed Sa Multispecific antibodies specifically binding to zika virus epitopes and uses thereof
US11571401B2 (en) 2017-09-01 2023-02-07 East Carolina University Compounds, compositions, kits, and methods for activating immune cells and/or an immune system response
JP7145895B2 (en) 2017-09-01 2022-10-03 四川科倫博泰生物医薬股▲フン▼有限公司 recombinant bispecific antibody
US20200407422A1 (en) 2017-09-05 2020-12-31 GLAdiator Biosciences, Inc. A method of intracellular delivery
GB2581619A (en) 2017-09-15 2020-08-26 Univ California Inhibition of aminoacylase 3 (AA3) in the treatment of cancer
US20200255828A1 (en) 2017-10-04 2020-08-13 The Broad Institute, Inc. Methods and compositions for altering function and structure of chromatin loops and/or domains
BR112020007183A2 (en) 2017-10-11 2020-09-24 Chemocentryx, Inc. treatment of segmented focal glomerulosclerosis with ccr2 antagonists
EP4116327A1 (en) 2017-10-11 2023-01-11 Board Of Regents, The University Of Texas System Human pd-l1 antibodies and methods of use therefor
CN111587123A (en) 2017-11-09 2020-08-25 品通治疗有限公司 Methods and compositions for generating and using humanized conformation-specific phosphorylated tau antibodies
CN109870581B (en) 2017-12-04 2021-05-04 厦门万泰凯瑞生物技术有限公司 Kit and method for quantitatively detecting HBsAg
BR112020011768A2 (en) 2017-12-15 2020-11-17 Syngenta Participations Ag different antibody ligands for detection of target proteins
US11851478B2 (en) 2018-01-05 2023-12-26 Vanderbilt University Antibody-mediated neutralization of chikungunya virus
WO2019155041A1 (en) 2018-02-12 2019-08-15 Vib Vzw Gβγ COMPLEX ANTIBODIES AND USES THEREOF
WO2019165217A1 (en) 2018-02-22 2019-08-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Cd153 and/or cd30 in infection
EA202091810A1 (en) 2018-03-02 2021-01-29 Файв Прайм Терапьютикс, Инк. ANTIBODIES TO B7-H4 AND METHODS OF THEIR APPLICATION
EP3768726A4 (en) 2018-03-23 2021-12-22 Board of Regents, The University of Texas System Dual specificity antibodies to pd-l1 and pd-l2 and methods of use therefor
US11788124B2 (en) 2018-04-09 2023-10-17 Advanced Cell Diagnostics, Inc. Methods to further enhance signal amplification for the in situ detection of nucleic acids
EP3785732A4 (en) 2018-04-24 2022-02-23 Ampsource Biopharma Shanghai Inc. Antibody against tim-3 and application thereof
WO2019213276A1 (en) 2018-05-02 2019-11-07 Novartis Ag Regulators of human pluripotent stem cells and uses thereof
TW202016144A (en) 2018-06-21 2020-05-01 日商第一三共股份有限公司 Compositions including cd3 antigen binding fragments and uses thereof
CA3109366A1 (en) 2018-09-13 2020-03-19 The Board Of Regents Of The University Of Texas System Novel lilrb4 antibodies and uses thereof
WO2020069424A1 (en) 2018-09-28 2020-04-02 Centrillion Technologies, Inc. Disulfide-linked reversible terminators
EA202191033A1 (en) 2018-10-15 2021-12-21 Юниверсити Оф Массачусетс PROGRAMMED DNA BASE EDITING VIA NME2CAS9-DEAMINASE fusion proteins
AU2019360758A1 (en) 2018-10-18 2021-05-20 Oklahoma Medical Research Foundation Biomarkers for a systemic lupus erythematosus (SLE) disease activity immune index that characterizes disease activity
BR112021007690A2 (en) 2018-10-22 2021-08-10 Shanghai GenBase Biotechnology Co., Ltd. anti-cldn18.2 antibody and its use
US20210388108A1 (en) 2018-10-23 2021-12-16 Glycardial Diagnostics, S.L. Antibodies specific for glycosylated apoj and uses thereof
CN111196851B (en) 2018-11-20 2021-11-16 厦门万泰凯瑞生物技术有限公司 Specific antibody aiming at human anti-mullerian hormone and application thereof
CN113423465A (en) 2018-11-28 2021-09-21 俄勒冈健康与科学大学 Therapeutic factor XII antibodies
EP3888021B1 (en) 2018-11-30 2024-02-21 Caris MPI, Inc. Next-generation molecular profiling
EP4292659A3 (en) 2018-12-19 2024-03-20 Humabs Biomed SA Antibodies that neutralize hepatitis b virus and uses thereof
CN113166246A (en) 2018-12-28 2021-07-23 四川科伦博泰生物医药股份有限公司 Antibody and application thereof
JP2022518489A (en) 2019-01-25 2022-03-15 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Compositions and Methods for Synthesizing Nucleic Acids
US20220154262A1 (en) 2019-02-15 2022-05-19 Advanced Cell Diagnostics, Inc. Methods for multiplex detection of nucleic acids by in situ hybridization
US10745492B1 (en) 2019-04-03 2020-08-18 Ark Diagnostics, Inc. Antibodies to symmetrically dimethylated arginine analytes and use thereof
WO2020211674A1 (en) 2019-04-16 2020-10-22 四川科伦博泰生物医药股份有限公司 Anti-fxi/fxia antibody and use thereof
EP3963099A1 (en) 2019-04-30 2022-03-09 Larimar Therapeutics, Inc. Frataxin-sensitive markers for determining effectiveness of frataxin replacement therapy
CA3138403A1 (en) 2019-05-20 2020-11-26 Christopher J. MACNEVIN Narrow emission dyes, compositions comprising same, and methods for making and using same
GB2598520A (en) 2019-05-28 2022-03-02 Univ Shanghai Technology Composition and methods to treat ectodermal dysplasia 2, Clouston type
JP2022538868A (en) 2019-06-26 2022-09-06 バイオーケストラ カンパニー， リミテッド Micelle nanoparticles and uses thereof
AU2020317009A1 (en) 2019-07-19 2022-02-03 The Board Of Trustees Of The Leland Stanford Junior University Chimeric antigen receptors containing Glypican 2 binding domains
CA3145278A1 (en) 2019-07-26 2021-02-04 Vanderbilt University Human monoclonal antibodies to enterovirus d68
US20210048436A1 (en) 2019-08-15 2021-02-18 Psychemedics Corporation Homogeneous enzyme immunoassay for keratinized structures
BR112022003698A2 (en) 2019-08-29 2022-05-24 Vir Biotechnology Inc Method of treating a hepatitis b virus infection and pharmaceutical composition
EP4032907A4 (en) 2019-09-20 2023-07-05 Shanghai Genbase Biotechnology Co., Ltd. Bcma-targeted antibody and chimeric antigen receptor
CN114729045A (en) 2019-09-26 2022-07-08 斯特库比公司 Antibodies specific for glycosylated CTLA-4 and methods of use thereof
EP4039704A4 (en) 2019-09-30 2023-09-20 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Anti-pd-1 antibody and use thereof
US20220356248A1 (en) 2019-10-09 2022-11-10 Stcube & Co Antibodies specific to glycosylated lag3 and methods of use thereof
US10792360B1 (en) 2019-11-21 2020-10-06 Chemocentryx, Inc. Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies
EP4069865A4 (en) 2019-12-02 2023-12-20 Caris MPI, Inc. Pan-cancer platinum response predictor
CN112898414B (en) 2019-12-04 2024-05-10 珠海泰诺麦博制药股份有限公司 Anti-human cytomegalovirus antibodies and uses thereof
WO2021119402A1 (en) 2019-12-12 2021-06-17 President And Fellows Of Harvard College Compositions and methods for light-directed biomolecular barcoding
JP2023505408A (en) 2019-12-13 2023-02-09 シチュアン ケルン－バイオテック バイオファーマシューティカル カンパニー リミテッド Anti-TSLP antibody and use thereof
JP2023509373A (en) 2019-12-20 2023-03-08 ノヴァロック バイオセラピューティクス， リミテッド ANTI-INTERLEUKIN-23 P19 ANTIBODY AND METHODS OF USE THEREOF
EP3842452A1 (en) 2019-12-26 2021-06-30 Universitat Autònoma de Barcelona Scaffold proteins and therapeutic nanoconjugates based on nidogen
CN113061165A (en) 2020-01-02 2021-07-02 厦门大学 EB virus BNLF2b gene encoding polypeptide and detection use thereof
WO2021156490A2 (en) 2020-02-06 2021-08-12 Vib Vzw Corona virus binders
EP4103602A1 (en) 2020-02-11 2022-12-21 Vanderbilt University Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (sars-cov- 2)
CA3168337A1 (en) 2020-02-17 2021-08-26 Marie-Andree Forget Methods for expansion of tumor infiltrating lymphocytes and use thereof
WO2021170540A1 (en) 2020-02-25 2021-09-02 Vib Vzw Leucine-rich repeat kinase 2 allosteric modulators
WO2021173674A1 (en) 2020-02-26 2021-09-02 A2 Biotherapeutics, Inc. Polypeptides targeting mage-a3 peptide-mhc complexes and methods of use thereof
PT4045533T (en) 2020-03-26 2024-02-14 Univ Vanderbilt Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
WO2021195385A1 (en) 2020-03-26 2021-09-30 Vanderbilt University HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-GoV-2)
TW202203916A (en) 2020-03-31 2022-02-01 美商卡默森屈有限公司 Compositions and methods for treating inflammatory bowel disease using ccr9 inhibitor and anti-il-23 blocking antibodies
CN116096884A (en) 2020-04-22 2023-05-09 哈佛大学校长及研究员协会 Isothermal methods, compositions, kits and systems for detecting nucleic acids
CR20220580A (en) 2020-05-15 2023-04-11 Sichuan Kelun Biotech Biopharmaceutical Co Ltd Antibody drug conjugate, preparation method therefor and use thereof
US20230242621A1 (en) 2020-06-24 2023-08-03 Vir Biotechnology, Inc. Engineered hepatitis b virus neutralizing antibodies and uses thereof
EP3939999A1 (en) 2020-07-14 2022-01-19 Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) Interleukin 11 receptor alpha subunit (il11ra) neutralizing antibodies and uses thereof
WO2022047359A1 (en) 2020-08-31 2022-03-03 Berg Llc Protein biomarkers for pancreatic cancer
EP4208259A2 (en) 2020-09-04 2023-07-12 NovaRock Biotherapeutics, Ltd. Nectin-4 antibodies and uses thereof
GB202105804D0 (en) 2020-11-20 2021-06-09 Univ Cape Town Use of microvirin in the identification of mycobacterium tuberculosis mannose-capped lipoarabinomannan
KR20230144525A (en) 2020-12-04 2023-10-16 유니버시티 오브 테네시 리서치 파운데이션 How to Diagnose Amyloid Disease
AU2021414160A1 (en) 2020-12-31 2023-07-20 Nona Biosciences (Suzhou) Co., Ltd. Human lifr antigen binding protein, preparation method therefor, and application thereof
TW202245838A (en) 2021-01-26 2022-12-01 美商維爾生物科技股份有限公司 Compositions and methods for treating hepatitis b virus infection
GB2603166A (en) 2021-01-29 2022-08-03 Thelper As Therapeutic and Diagnostic Agents and Uses Thereof
TW202241521A (en) 2021-02-09 2022-11-01 大陸商蘇州宜聯生物醫藥有限公司 Biologically active conjugate and preparation method and use thereof
EP4294516A1 (en) 2021-02-19 2023-12-27 Vib Vzw Cation-independent mannose-6-phosphate receptor binders
JP2024512337A (en) 2021-03-05 2024-03-19 シャンハイ、ケンパーソー、バイオテクノロジー、カンパニー、リミテッド Anti-CLDN6 antibody and its use
TW202302155A (en) 2021-03-08 2023-01-16 美商伊繆諾金公司 Methods for increasing efficacy of immunoconjugates targeting adam9 for the treatment of cancer
EP4306540A1 (en) 2021-03-09 2024-01-17 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Ror1 binding protein and use thereof
WO2022189558A2 (en) 2021-03-10 2022-09-15 Mabylon Ag Antibodies against tdp-43 and methods of using the same
IL307530A (en) 2021-04-06 2023-12-01 Bpgbio Inc Protein markers for estrogen receptor (er)-positive luminal a(la)-like and luminal b1 (lb1)-like breast cancer
IL307528A (en) 2021-04-06 2023-12-01 Bpgbio Inc Protein markers for the prognosis of breast cancer progression
WO2022216846A1 (en) 2021-04-06 2022-10-13 Berg Llc Protein markers for estrogen receptor (er)-positive-like and estrogen receptor (er)-negative-like breast cancer
JP2024515726A (en) 2021-04-19 2024-04-10 テンプル セラピューティクス ビーブイ Methods for detecting or treating endometrial and ovarian hyperproliferative disorders - Patents.com
EP4370160A1 (en) 2021-07-15 2024-05-22 President And Fellows Of Harvard College Compositions and methods relating to cells with adhered particles
WO2023016828A2 (en) 2021-07-30 2023-02-16 Vib Vzw Cation-independent mannose-6-phosphate receptor binders for targeted protein degradation
WO2023081070A1 (en) 2021-11-02 2023-05-11 University Of Massachusetts Nme2Cas9 INLAID DOMAIN FUSION PROTEINS
WO2023089377A2 (en) 2021-11-19 2023-05-25 Mirobio Limited Engineered pd-1 antibodies and uses thereof
GB202201137D0 (en) 2022-01-28 2022-03-16 Thelper As Therapeutic and diagnostic agents and uses thereof
EP4238988A1 (en) 2022-03-01 2023-09-06 Consejo Superior De Investigaciones Científicas Antibodies against sars-cov-2 and uses thereof
TW202405011A (en) 2022-04-01 2024-02-01 美國德州系統大學評議委員會 Dual specificity antibodies to human pd-l1 and pd-l2 and methods of use therefor
GB202204813D0 (en) 2022-04-01 2022-05-18 Bradcode Ltd Human monoclonal antibodies and methods of use thereof
WO2023196937A1 (en) 2022-04-06 2023-10-12 Larimar Therapeutics, Inc. Frataxin-sensitive markers for monitoring frataxin replacement therapy
US20230416361A1 (en) 2022-04-06 2023-12-28 Mirobio Limited Engineered cd200r antibodies and uses thereof
WO2023240201A1 (en) 2022-06-08 2023-12-14 Larimar Therapeutics, Inc. Frataxin-sensitive markers for monitoring progression and treatment of leigh syndrome
WO2023239710A1 (en) 2022-06-08 2023-12-14 Onkure, Inc. Benzopyrimidin-4(3h)-ones as pi3k inhibitors
WO2023239940A1 (en) 2022-06-10 2023-12-14 Research Development Foundation Engineered fcriib selective igg1 fc variants and uses thereof
WO2024028794A1 (en) 2022-08-02 2024-02-08 Temple Therapeutics BV Methods for treating endometrial and ovarian hyperproliferative disorders
WO2024040020A1 (en) 2022-08-15 2024-02-22 Absci Corporation Quantitative affinity activity specific cell enrichment
WO2024038160A1 (en) 2022-08-18 2024-02-22 Vib Vzw Means and methods to modulate neuron excitability
WO2024054469A1 (en) 2022-09-08 2024-03-14 Onkure, Inc. Isoquinolones as pi3k inhibitors
WO2024064024A1 (en) 2022-09-19 2024-03-28 Onkure, Inc. ((4-oxo-3,4-dihydroquinazolin-8-yl)methyl)amine derivatives as p13k inhibitors for the treatment of cancer
WO2024064002A1 (en) 2022-09-20 2024-03-28 Onkure, Inc. Hdac inhibitor oki-179 for the treatment of cancers resulting from a mapk pathway mutation
WO2024068744A1 (en) 2022-09-27 2024-04-04 Vib Vzw Antivirals against human parainfluenza virus
WO2024081345A1 (en) 2022-10-14 2024-04-18 Onkure, Inc. Benzopyrimidin-4(3h)-ones as pi3k inhibitors
WO2024102466A2 (en) 2022-11-11 2024-05-16 Igan Biosciences Iga protease polypeptide agents

Also Published As

Publication number Publication date
US3817837A (en) 1974-06-18

Similar Documents

Publication Publication Date Title
BE846194Q (en) DOSAGE BY ENZYMATIC AMPLIFICATION
NL155939C (en) AIR TREATMENT PLANT.
NL169239C (en) POWER AMPLIFIER.
NL166589C (en) AMPLIFIER CHAIN.
SE7506821L (en) PHENYLALANE DERIVATIVES.
BE772636A (en) ENZYMES
NL169005C (en) AMPLIFIER CHAIN.
OA04164A (en) Enzyme-polymer complexes.
TR17083A (en) KOEMUERUE GASIZING PLANT
NL170579C (en) AMPLIFIER CHAIN.
SE412391B (en) AB STOCKHOLMS PATENTBYRA
BE767978A (en) GARDEN
AT312687B (en) Line amplifier
SE381149B (en) TRANSISTOR AMPLIFIERS
BE771834A (en) ENZYMES
AT323109B (en) ENZYMATIC ANALYZES
AT313453B (en) Induced draft amplifier
FI51658C (en) Disintegrator.
SE380589B (en) FLUIDISTOR AMPLIFIER
BE775067A (en) AMPLIFIER
AT315027B (en) Target
BR7105463D0 (en) NEW CONCENTRATED FERTILIZER
BE768324A (en) ARTICULATOR.
SE387739B (en) HYDRAULIC VAG
ES166651Y (en) SINGLE PIECE FLANGE.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: SYVA CY

Effective date: 19940618

RE20 Patent expired

Owner name: SYVA CY

Effective date: 19960914